,index,active_ingredient_moiety,nda_bla,approval_year,active,DrugBank ID,Drug Groups,SMILES,Name,Drug Type
0,0,troglitazone,NDA,1997,troglitazone,DB00197,approved; investigational; withdrawn,CC1=C(C)C2=C(CCC(C)(COC3=CC=C(CC4SC(=O)NC4=O)C=C3)O2)C(C)=C1O,Troglitazone,SmallMoleculeDrug
1,1,imiquimod,NDA,1997,imiquimod,DB00724,approved; investigational,CC(C)CN1C=NC2=C1C1=C(C=CC=C1)N=C2N,Imiquimod,SmallMoleculeDrug
2,2,anagrelide hydrochloride,NDA,1997,anagrelide,DB00261,approved,ClC1=CC=C2N=C3NC(=O)CN3CC2=C1Cl,Anagrelide,SmallMoleculeDrug
3,3,nelfinavir mesylate,NDA,1997,nelfinavir,DB00220,approved,[H][C@@]12CCCC[C@]1([H])CN(C[C@@H](O)[C@H](CSC1=CC=CC=C1)NC(=O)C1=C(C)C(O)=CC=C1)[C@@H](C2)C(=O)NC(C)(C)C,Nelfinavir,SmallMoleculeDrug
4,4,delavirdine mesylate,NDA,1997,delavirdine,DB00705,approved,CC(C)NC1=C(N=CC=C1)N1CCN(CC1)C(=O)C1=CC2=C(N1)C=CC(NS(C)(=O)=O)=C2,Delavirdine,SmallMoleculeDrug
5,5,tamsulosin hydrochloride,NDA,1997,tamsulosin,DB00706,approved; investigational,CCOC1=CC=CC=C1OCCN[C@H](C)CC1=CC(=C(OC)C=C1)S(N)(=O)=O,Tamsulosin,SmallMoleculeDrug
6,6,toremifene citrate,NDA,1997,toremifene,DB00539,approved; investigational,CN(C)CCOC1=CC=C(C=C1)C(=C(\CCCl)C1=CC=CC=C1)\C1=CC=CC=C1,Toremifene,SmallMoleculeDrug
7,7,tazarotene,NDA,1997,tazarotene,DB00799,approved; investigational,CCOC(=O)C1=CN=C(C=C1)C#CC1=CC2=C(SCCC2(C)C)C=C1,Tazarotene,SmallMoleculeDrug
8,8,cerivastatin sodium,NDA,1997,cerivastatin,DB00439,approved; withdrawn,COCC1=C(C2=CC=C(F)C=C2)C(\C=C\[C@@H](O)C[C@@H](O)CC(O)=O)=C(C(C)C)N=C1C(C)C,Cerivastatin,SmallMoleculeDrug
9,9,pramipexole dihydrochloride,NDA,1997,pramipexole,DB00413,approved; investigational,CCCN[C@H]1CCC2=C(C1)SC(N)=N2,Pramipexole,SmallMoleculeDrug
10,10,bromfenac sodium,NDA,1997,bromfenac,DB00963,approved,NC1=C(CC(O)=O)C=CC=C1C(=O)C1=CC=C(Br)C=C1,Bromfenac,SmallMoleculeDrug
11,11,letrozole,NDA,1997,letrozole,DB01006,approved; investigational,N#CC1=CC=C(C=C1)C(N1C=NC=N1)C1=CC=C(C=C1)C#N,Letrozole,SmallMoleculeDrug
12,12,dolasetron mesylate,NDA,1997,dolasetron,DB00757,approved; investigational,[H][C@@]1(C[C@@]2([H])C[C@]3([H])C[C@@]([H])(C1)N2CC3=O)OC(=O)C1=CNC2=C1C=CC=C2,Dolasetron,SmallMoleculeDrug
13,13,arbutamine hydrochloride,NDA,1997,arbutamine,DB01102,approved,O[C@@H](CNCCCCC1=CC=C(O)C=C1)C1=CC(O)=C(O)C=C1,Arbutamine,SmallMoleculeDrug
14,14,ropinirole hydrochloride,NDA,1997,ropinirole,DB00268,approved; investigational,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1,Ropinirole,SmallMoleculeDrug
15,15,fenoldopam mesylate,NDA,1997,fenoldopam,DB00800,approved,OC1=CC=C(C=C1)C1CNCCC2=C(Cl)C(O)=C(O)C=C12,Fenoldopam,SmallMoleculeDrug
16,16,quetiapine fumarate,NDA,1997,quetiapine,DB01224,approved,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,Quetiapine,SmallMoleculeDrug
17,17,tiagabine hydrochloride,NDA,1997,tiagabine,DB00906,approved; investigational,CC1=C(SC=C1)C(=CCCN1CCC[C@H](C1)C(O)=O)C1=C(C)C=CS1,Tiagabine,SmallMoleculeDrug
18,18,irbesartan,NDA,1997,irbesartan,DB01029,approved; investigational,CCCCC1=NC2(CCCC2)C(=O)N1CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1,Irbesartan,SmallMoleculeDrug
19,19,grepafloxacin hydrochloride,NDA,1997,grepafloxacin,DB00365,approved; investigational; withdrawn,CC1CN(CCN1)C1=C(F)C(C)=C2C(=O)C(=CN(C3CC3)C2=C1)C(O)=O,Grepafloxacin,SmallMoleculeDrug
20,20,clopidogrel bisulfate,NDA,1997,clopidogrel,DB00758,approved,[H][C@@](N1CCC2=C(C1)C=CS2)(C(=O)OC)C1=CC=CC=C1Cl,Clopidogrel,SmallMoleculeDrug
21,21,sibutramine hydrochloride,NDA,1997,sibutramine,DB01105,approved; illicit; investigational; withdrawn,CC(C)CC(N(C)C)C1(CCC1)C1=CC=C(Cl)C=C1,Sibutramine,SmallMoleculeDrug
22,22,zolmitriptan,NDA,1997,zolmitriptan,DB00315,approved; investigational,CN(C)CCC1=CNC2=CC=C(C[C@H]3COC(=O)N3)C=C12,Zolmitriptan,SmallMoleculeDrug
23,23,mangafodipir trisodium,NDA,1997,mangafodipir,DB06796,approved; investigational; withdrawn,[Mn++].CC1=C(O)C(CN(CCN(CC([O-])=O)CC2=CC(COP(O)(O)=O)=NC(C)=C2O)CC([O-])=O)=CC(COP(O)(O)=O)=N1,Mangafodipir,SmallMoleculeDrug
24,24,cefdinir,NDA,1997,cefdinir,DB00535,approved,[H][C@]12SCC(C=C)=C(N1C(=O)[C@H]2NC(=O)C(=N/O)\C1=CSC(N)=N1)C(O)=O,Cefdinir,SmallMoleculeDrug
25,25,fomepizole,NDA,1997,fomepizole,DB01213,approved; vet_approved,CC1=CNN=C1,Fomepizole,SmallMoleculeDrug
26,26,raloxifene hydrochloride,NDA,1997,raloxifene,DB00481,approved; investigational,OC1=CC=C(C=C1)C1=C(C(=O)C2=CC=C(OCCN3CCCCC3)C=C2)C2=C(S1)C=C(O)C=C2,Raloxifene,SmallMoleculeDrug
27,27,alatrofloxacin mesylate,NDA,1997,alatrofloxacin,DB09335,approved; withdrawn,[H][C@@]12CN(C[C@]1([H])[C@H]2NC(=O)[C@H](C)NC(=O)[C@H](C)N)C1=NC2=C(C=C1F)C(=O)C(=CN2C1=CC=C(F)C=C1F)C(O)=O,Alatrofloxacin,SmallMoleculeDrug
28,28,trovafloxacin mesylate,NDA,1997,trovafloxacin,DB00685,approved; investigational; withdrawn,[H][C@@]12CN(C[C@]1([H])[C@H]2N)C1=NC2=C(C=C1F)C(=O)C(=CN2C1=C(F)C=C(F)C=C1)C(O)=O,Trovafloxacin,SmallMoleculeDrug
29,29,eprosartan mesylate,NDA,1997,eprosartan,DB00876,approved,CCCCC1=NC=C(\C=C(/CC2=CC=CS2)C(O)=O)N1CC1=CC=C(C=C1)C(O)=O,Eprosartan,SmallMoleculeDrug
30,30,repaglinide,NDA,1997,repaglinide,DB00912,approved; investigational,CCOC1=C(C=CC(CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N2CCCCC2)=C1)C(O)=O,Repaglinide,SmallMoleculeDrug
31,31,talc,NDA,1997,talc,DB09511,approved,[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[Mg++].[Mg++].[Mg++].[Si+4].[Si+4].[Si+4].[Si+4].[O-][H].[O-][H],Talc,SmallMoleculeDrug
32,32,emedastine difumarate,NDA,1997,emedastine,DB01084,approved,CCOCCN1C(=NC2=CC=CC=C12)N1CCCN(C)CC1,Emedastine,SmallMoleculeDrug
33,33,tolcapone,NDA,1998,tolcapone,DB00323,approved; withdrawn,CC1=CC=C(C=C1)C(=O)C1=CC(=C(O)C(O)=C1)[N+]([O-])=O,Tolcapone,SmallMoleculeDrug
34,34,naratriptan,NDA,1998,naratriptan,DB00952,approved; investigational,CNS(=O)(=O)CCC1=CC2=C(NC=C2C2CCN(C)CC2)C=C1,Naratriptan,SmallMoleculeDrug
35,35,montelukast sodium,NDA,1998,montelukast,DB00471,approved,OC(=O)CC1(CC1)CS[C@H](CCC1=CC=CC=C1C(O)(C)C)C1=CC=CC(\C=C\C2=NC3=C(C=CC(Cl)=C3)C=C2)=C1,Montelukast,SmallMoleculeDrug
36,36,loteprednol etabonate,NDA,1998,loteprednol etabonate,DB14596,approved,[H][C@@]12CC[C@](OC(=O)OCC)(C(=O)OCCl)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,Loteprednol etabonate,SmallMoleculeDrug
37,37,tolterodine tartrate,NDA,1998,tolterodine,DB01036,approved; investigational,CC(C)N(CC[C@H](C1=CC=CC=C1)C1=C(O)C=CC(C)=C1)C(C)C,Tolterodine,SmallMoleculeDrug
38,38,sildenafil citrate,NDA,1998,sildenafil,DB00203,approved; investigational,CCCC1=NN(C)C2=C1N=C(NC2=O)C1=CC(=CC=C1OCC)S(=O)(=O)N1CCN(C)CC1,Sildenafil,SmallMoleculeDrug
39,39,brinzolamide,NDA,1998,brinzolamide,DB01194,approved,CCN[C@H]1CN(CCCOC)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O,Brinzolamide,SmallMoleculeDrug
40,40,paricalcitol,NDA,1998,paricalcitol,DB00910,approved; investigational,[H][C@@]1(CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1C[C@@H](O)C[C@H](O)C1)[C@H](C)\C=C\[C@H](C)C(C)(C)O,Paricalcitol,SmallMoleculeDrug
41,41,capecitabine,NDA,1998,capecitabine,DB01101,approved; investigational,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@@H]1O[C@H](C)[C@@H](O)[C@H]1O,Capecitabine,SmallMoleculeDrug
42,42,tirofiban hydrochloride,NDA,1998,tirofiban,DB00775,approved,CCCCS(=O)(=O)N[C@@H](CC1=CC=C(OCCCCC2CCNCC2)C=C1)C(O)=O,Tirofiban,SmallMoleculeDrug
43,43,rifapentine,NDA,1998,rifapentine,DB01201,approved; investigational,CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C2=O)C2=C(C(O)=C3C)C(O)=C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(\C=N\N1CCN(CC1)C1CCCC1)=C2O,Rifapentine,SmallMoleculeDrug
44,44,rizatriptan benzoate,NDA,1998,rizatriptan,DB00953,approved,CN(C)CCC1=CNC2=C1C=C(CN1C=NC=N1)C=C2,Rizatriptan,SmallMoleculeDrug
45,45,thalidomide,NDA,1998,thalidomide,DB01041,approved; investigational; withdrawn,O=C1N(C2CCC(=O)NC2=O)C(=O)C2=CC=CC=C12,Thalidomide,SmallMoleculeDrug
46,46,citalopram hydrobromide,NDA,1998,citalopram,DB00215,approved,CN(C)CCCC1(OCC2=C1C=CC(=C2)C#N)C1=CC=C(F)C=C1,Citalopram,SmallMoleculeDrug
47,47,leflunomide,NDA,1998,leflunomide,DB01097,approved; investigational,CC1=C(C=NO1)C(=O)NC1=CC=C(C=C1)C(F)(F)F,Leflunomide,SmallMoleculeDrug
48,48,efavirenz,NDA,1998,efavirenz,DB00625,approved; investigational,FC(F)(F)[C@]1(OC(=O)NC2=C1C=C(Cl)C=C2)C#CC1CC1,Efavirenz,SmallMoleculeDrug
49,49,valrubicin,NDA,1998,valrubicin,DB00385,approved,[H][C@@]1(C[C@@](O)(CC2=C(O)C3=C(C(O)=C12)C(=O)C1=C(OC)C=CC=C1C3=O)C(=O)COC(=O)CCCC)O[C@H]1C[C@H](NC(=O)C(F)(F)F)[C@H](O)[C@H](C)O1,Valrubicin,SmallMoleculeDrug
50,50,sevelamer hydrochloride,NDA,1998,sevelamer,DB00658,approved,NCC=C.ClCC1CO1,Sevelamer,SmallMoleculeDrug
51,51,telmisartan,NDA,1998,telmisartan,DB00966,approved; investigational,CCCC1=NC2=C(C=C(C=C2C)C2=NC3=CC=CC=C3N2C)N1CC1=CC=C(C=C1)C1=CC=CC=C1C(O)=O,Telmisartan,SmallMoleculeDrug
52,52,abacavir sulfate,NDA,1998,abacavir,DB01048,approved; investigational,NC1=NC2=C(N=CN2[C@@H]2C[C@H](CO)C=C2)C(NC2CC2)=N1,Abacavir,SmallMoleculeDrug
53,53,modafinil,NDA,1998,modafinil,DB00745,approved; investigational,NC(=O)CS(=O)C(C1=CC=CC=C1)C1=CC=CC=C1,Modafinil,SmallMoleculeDrug
54,54,celecoxib,NDA,1998,celecoxib,DB00482,approved; investigational,CC1=CC=C(C=C1)C1=CC(=NN1C1=CC=C(C=C1)S(N)(=O)=O)C(F)(F)F,Celecoxib,SmallMoleculeDrug
55,55,cilostazol,NDA,1999,cilostazol,DB01166,approved; investigational,O=C1CCC2=C(N1)C=CC(OCCCCC1=NN=NN1C1CCCCC1)=C2,Cilostazol,SmallMoleculeDrug
56,56,alitretinoin,NDA,1999,alitretinoin,DB00523,approved; investigational,C\C(\C=C\C1=C(C)CCCC1(C)C)=C\C=C\C(\C)=C\C(O)=O,Alitretinoin,SmallMoleculeDrug
57,57,amprenavir,NDA,1999,amprenavir,DB00701,approved; investigational,CC(C)CN(C[C@@H](O)[C@H](CC1=CC=CC=C1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)C1=CC=C(N)C=C1,Amprenavir,SmallMoleculeDrug
58,58,orlistat,NDA,1999,orlistat,DB01083,approved; investigational,CCCCCCCCCCC[C@@H](C[C@@H]1OC(=O)[C@H]1CCCCCC)OC(=O)[C@H](CC(C)C)NC=O,Orlistat,SmallMoleculeDrug
59,59,rofecoxib,NDA,1999,rofecoxib,DB00533,approved; investigational; withdrawn,CS(=O)(=O)C1=CC=C(C=C1)C1=C(C(=O)OC1)C1=CC=CC=C1,Rofecoxib,SmallMoleculeDrug
60,60,rosiglitazone maleate,NDA,1999,rosiglitazone,DB00412,approved; investigational,CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C1=CC=CC=N1,Rosiglitazone,SmallMoleculeDrug
61,61,doxercalciferol,NDA,1999,doxercalciferol,DB06410,approved,[H][C@@]1(CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C)[C@H](C)\C=C\[C@H](C)C(C)C,Doxercalciferol,SmallMoleculeDrug
62,62,ketotifen fumarate,NDA,1999,ketotifen,DB00920,approved,CN1CCC(CC1)=C1C2=C(SC=C2)C(=O)CC2=CC=CC=C12,Ketotifen,SmallMoleculeDrug
63,63,pioglitazone hydrochloride,NDA,1999,pioglitazone,DB01132,approved; investigational,CCC1=CN=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1,Pioglitazone,SmallMoleculeDrug
64,64,zanamivir,NDA,1999,zanamivir,DB00558,approved; investigational,[H][C@]1(OC(=C[C@H](N=C(N)N)[C@H]1NC(C)=O)C(O)=O)[C@H](O)[C@H](O)CO,Zanamivir,SmallMoleculeDrug
65,65,ganirelix acetate,NDA,1999,ganirelix,DB06785,approved,CCNC(NCC)=NCCCC[C@@H](NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@@H](CC1=CC=CN=C1)NC(=O)[C@@H](CC1=CC=C(Cl)C=C1)NC(=O)[C@@H](CC1=CC2=CC=CC=C2C=C1)NC(C)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN=C(NCC)NCC)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O,Ganirelix,SmallMoleculeDrug
66,66,temozolomide,NDA,1999,temozolomide,DB00853,approved; investigational,CN1N=NC2=C(N=CN2C1=O)C(N)=O,Temozolomide,SmallMoleculeDrug
67,67,zaleplon,NDA,1999,zaleplon,DB00962,approved; illicit; investigational,CCN(C(C)=O)C1=CC=CC(=C1)C1=CC=NC2=C(C=NN12)C#N,Zaleplon,SmallMoleculeDrug
68,68,rapacuronium bromide,NDA,1999,rapacuronium,DB04834,approved; withdrawn,[H][C@@]12C[C@@H]([C@H](OC(=O)CC)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@H](OC(C)=O)[C@H](C[C@]12C)N1CCCCC1)[N+]1(CC=C)CCCCC1,Rapacuronium,SmallMoleculeDrug
69,69,rabeprazole sodium,NDA,1999,rabeprazole,DB01129,approved; investigational,COCCCOC1=C(C)C(CS(=O)C2=NC3=CC=CC=C3N2)=NC=C1,Rabeprazole,SmallMoleculeDrug
70,70,epirubicin hydrochloride,NDA,1999,epirubicin,DB00445,approved,COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(C[C@](O)(C[C@@H]3O[C@H]3C[C@H](N)[C@@H](O)[C@H](C)O3)C(=O)CO)C(O)=C1C2=O,Epirubicin,SmallMoleculeDrug
71,71,sirolimus,NDA,1999,sirolimus,DB00877,approved; investigational,[H][C@@]1(C[C@@H](C)[C@]2([H])CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@]3([H])CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@@]3([H])C(=O)O2)OC)CC[C@@H](O)[C@@H](C1)OC,Sirolimus,SmallMoleculeDrug
72,72,dofetilide,NDA,1999,dofetilide,DB00204,approved; investigational,CN(CCOC1=CC=C(NS(C)(=O)=O)C=C1)CCC1=CC=C(NS(C)(=O)=O)C=C1,Dofetilide,SmallMoleculeDrug
73,73,entacapone,NDA,1999,entacapone,DB00494,approved; investigational,CCN(CC)C(=O)C(=C\C1=CC(=C(O)C(O)=C1)[N+]([O-])=O)\C#N,Entacapone,SmallMoleculeDrug
74,74,exemestane,NDA,1999,exemestane,DB00990,approved; investigational,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC(=C)C2=CC(=O)C=C[C@]12C,Exemestane,SmallMoleculeDrug
75,75,oseltamivir phosphate,NDA,1999,oseltamivir,DB00198,approved,CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1,Oseltamivir,SmallMoleculeDrug
76,76,levetiracetam,NDA,1999,levetiracetam,DB01202,approved,CC[C@H](N1CCCC1=O)C(N)=O,Levetiracetam,SmallMoleculeDrug
77,77,aminolevulinic acid hydrochloride,NDA,1999,aminolevulinic acid,DB00855,approved,NCC(=O)CCC(O)=O,Aminolevulinic acid,SmallMoleculeDrug
78,78,gadoversetamide,NDA,1999,gadoversetamide,DB00538,approved; investigational,[Gd+3].COCCNC(=O)CN(CCN(CCN(CC([O-])=O)CC(=O)NCCOC)CC([O-])=O)CC([O-])=O,Gadoversetamide,SmallMoleculeDrug
79,79,moxifloxacin hydrochloride,NDA,1999,moxifloxacin,DB00218,approved; investigational,[H][C@]12CN(C[C@@]1([H])NCCC2)C1=C(F)C=C2C(=O)C(=CN(C3CC3)C2=C1OC)C(O)=O,Moxifloxacin,SmallMoleculeDrug
80,80,dexmedetomidine hydrochloride,NDA,1999,dexmedetomidine,DB00633,approved; vet_approved,C[C@H](C1=CNC=N1)C1=C(C)C(C)=CC=C1,Dexmedetomidine,SmallMoleculeDrug
81,81,gatifloxacin,NDA,1999,gatifloxacin,DB01044,approved; investigational,COC1=C2N(C=C(C(O)=O)C(=O)C2=CC(F)=C1N1CCNC(C)C1)C1CC1,Gatifloxacin,SmallMoleculeDrug
82,82,nitric oxide,NDA,1999,nitric oxide,DB00435,approved,[N]=O,Nitric Oxide,SmallMoleculeDrug
83,83,bexarotene,NDA,1999,bexarotene,DB00307,approved; investigational,CC1=CC2=C(C=C1C(=C)C1=CC=C(C=C1)C(O)=O)C(C)(C)CCC2(C)C,Bexarotene,SmallMoleculeDrug
84,84,cevimeline hydrochloride,NDA,2000,cevimeline,DB00185,approved,CC1O[C@@]2(CS1)CN1CCC2CC1,Cevimeline,SmallMoleculeDrug
85,85,oxcarbazepine,NDA,2000,oxcarbazepine,DB00776,approved,NC(=O)N1C2=CC=CC=C2CC(=O)C2=C1C=CC=C2,Oxcarbazepine,SmallMoleculeDrug
86,86,pantoprazole sodium,NDA,2000,pantoprazole,DB00213,approved,COC1=C(OC)C(CS(=O)C2=NC3=C(N2)C=C(OC(F)F)C=C3)=NC=C1,Pantoprazole,SmallMoleculeDrug
87,87,alosetron hydrochloride,NDA,2000,alosetron,DB00969,approved; withdrawn,CN1C2=C(C3=CC=CC=C13)C(=O)N(CC1=C(C)NC=N1)CC2,Alosetron,SmallMoleculeDrug
88,88,zonisamide,NDA,2000,zonisamide,DB00909,approved; investigational,NS(=O)(=O)CC1=NOC2=CC=CC=C12,Zonisamide,SmallMoleculeDrug
89,89,verteporfin,NDA,2000,verteporfin,DB00460,approved; investigational,COC(=O)CCC1=C2NC(\C=C3/N=C(/C=C4\N\C(=C/C5=N/C(=C\2)/C(CCC(O)=O)=C5C)C(C=C)=C4C)C2=CC=C([C@@H](C(=O)OC)[C@@]32C)C(=O)OC)=C1C,Verteporfin,SmallMoleculeDrug
90,90,meloxicam,NDA,2000,meloxicam,DB00814,approved; vet_approved,CN1C(C(=O)NC2=NC=C(C)S2)=C(O)C2=C(C=CC=C2)S1(=O)=O,Meloxicam,SmallMoleculeDrug
91,91,linezolid,NDA,2000,linezolid,DB00601,approved; investigational,CC(=O)NC[C@H]1CN(C(=O)O1)C1=CC(F)=C(C=C1)N1CCOCC1,Linezolid,SmallMoleculeDrug
92,92,rivastigmine tartrate,NDA,2000,rivastigmine,DB00989,approved; investigational,CCN(C)C(=O)OC1=CC=CC(=C1)[C@H](C)N(C)C,Rivastigmine,SmallMoleculeDrug
93,93,argatroban,NDA,2000,argatroban,DB00278,approved; investigational,C[C@@H]1CCN([C@H](C1)C(O)=O)C(=O)[C@H](CCCNC(N)=N)NS(=O)(=O)C1=CC=CC2=C1NCC(C)C2,Argatroban,SmallMoleculeDrug
94,94,balsalazide disodium,NDA,2000,balsalazide,DB01014,approved; investigational,OC(=O)CCNC(=O)C1=CC=C(C=C1)\N=N\C1=CC=C(O)C(=C1)C(O)=O,Balsalazide,SmallMoleculeDrug
95,95,docosanol,NDA,2000,docosanol,DB00632,approved; investigational,CCCCCCCCCCCCCCCCCCCCCCO,Docosanol,SmallMoleculeDrug
96,96,cetrorelix acetate,NDA,2000,cetrorelix,DB00050,approved; investigational,CC(C)C[C@H](NC(=O)[C@@H](CCCNC(N)=O)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@@H](CC1=CN=CC=C1)NC(=O)[C@@H](CC1=CC=C(Cl)C=C1)NC(=O)[C@@H](CC1=CC2=CC=CC=C2C=C1)NC(C)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O,Cetrorelix,SmallMoleculeDrug
97,97,arsenic trioxide,NDA,2000,arsenic trioxide,DB01169,approved; investigational,O=[As]O[As]=O,Arsenic trioxide,SmallMoleculeDrug
98,98,mifepristone,NDA,2000,mifepristone,DB00834,approved; investigational,[H][C@@]12CC[C@@](O)(C#CC)[C@@]1(C)C[C@H](C1=CC=C(C=C1)N(C)C)C1=C3CCC(=O)C=C3CC[C@@]21[H],Mifepristone,SmallMoleculeDrug
99,99,bivalirudin,NDA,2000,bivalirudin,DB00006,approved; investigational,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](N)CC1=CC=CC=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(O)=O,Bivalirudin,SmallMoleculeDrug
100,100,nateglinide,NDA,2000,nateglinide,DB00731,approved; investigational,CC(C)[C@H]1CC[C@@H](CC1)C(=O)N[C@H](CC1=CC=CC=C1)C(O)=O,Nateglinide,SmallMoleculeDrug
101,101,caspofungin acetate,NDA,2001,caspofungin,DB00520,approved,[H][C@@]12C[C@@H](O)CN1C(=O)[C@@H](NC(=O)[C@]([H])(C[C@@H](O)[C@@H](NCCN)NC(=O)[C@@H]1[C@@H](O)CCN1C(=O)[C@@H](NC(=O)[C@@H](NC2=O)[C@H](O)[C@@H](O)C1=CC=C(O)C=C1)[C@H](O)CCN)NC(=O)CCCCCCCC[C@@H](C)C[C@@H](C)CC)[C@@H](C)O,Caspofungin,SmallMoleculeDrug
102,102,ziprasidone hydrochloride,NDA,2001,ziprasidone,DB00246,approved,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1,Ziprasidone,SmallMoleculeDrug
103,103,formoterol fumarate,NDA,2001,formoterol,DB00983,approved; investigational,COC1=CC=C(CC(C)NCC(O)C2=CC(NC=O)=C(O)C=C2)C=C1,Formoterol,SmallMoleculeDrug
104,104,galantamine hydrobromide,NDA,2001,galantamine,DB00674,approved,[H][C@]12C[C@@H](O)C=C[C@]11CCN(C)CC3=C1C(O2)=C(OC)C=C3,Galantamine,SmallMoleculeDrug
105,105,travoprost,NDA,2001,travoprost,DB00287,approved,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)COC1=CC=CC(=C1)C(F)(F)F,Travoprost,SmallMoleculeDrug
106,106,bimatoprost,NDA,2001,bimatoprost,DB00905,approved; investigational,CCNC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)CCC1=CC=CC=C1,Bimatoprost,SmallMoleculeDrug
107,107,almotriptan malate,NDA,2001,almotriptan,DB00918,approved; investigational,CN(C)CCC1=CNC2=C1C=C(CS(=O)(=O)N1CCCC1)C=C2,Almotriptan,SmallMoleculeDrug
108,108,imatinib mesylate,NDA,2001,imatinib,DB00619,approved,CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)CC1,Imatinib,SmallMoleculeDrug
109,109,zoledronic acid,NDA,2001,zoledronic acid,DB00399,approved,OC(CN1C=CN=C1)(P(O)(O)=O)P(O)(O)=O,Zoledronic acid,SmallMoleculeDrug
110,110,tenofovir disoproxil fumarate,NDA,2001,tenofovir disoproxil,DB00300,approved; investigational,[H][C@@](C)(CN1C=NC2=C(N)N=CN=C12)OCP(=O)(OCOC(=O)OC(C)C)OCOC(=O)OC(C)C,Tenofovir disoproxil,SmallMoleculeDrug
111,111,frovatriptan,NDA,2001,frovatriptan,DB00998,approved; investigational,CN[C@@H]1CCC2=C(C1)C1=C(N2)C=CC(=C1)C(N)=O,Frovatriptan,SmallMoleculeDrug
112,112,valdecoxib,NDA,2001,valdecoxib,DB00580,approved; investigational; withdrawn,CC1=C(C(=NO1)C1=CC=CC=C1)C1=CC=C(C=C1)S(N)(=O)=O,Valdecoxib,SmallMoleculeDrug
113,113,dutasteride,NDA,2001,dutasteride,DB01126,approved; investigational,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC[C@@]4([H])NC(=O)C=C[C@]4(C)[C@@]3([H])CC[C@]12C)C(=O)NC1=CC(=CC=C1C(F)(F)F)C(F)(F)F,Dutasteride,SmallMoleculeDrug
114,114,bosentan,NDA,2001,bosentan,DB00559,approved; investigational,COC1=CC=CC=C1OC1=C(NS(=O)(=O)C2=CC=C(C=C2)C(C)(C)C)N=C(N=C1OCCO)C1=NC=CC=N1,Bosentan,SmallMoleculeDrug
115,115,ertapenem sodium,NDA,2001,ertapenem,DB00303,approved; investigational,[H][C@]12[C@@H](C)C(S[C@]3([H])CN[C@@]([H])(C3)C(=O)NC3=CC=CC(=C3)C(O)=O)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(O)=O,Ertapenem,SmallMoleculeDrug
116,116,fondaparinux sodium,NDA,2001,fondaparinux,DB00569,approved; investigational,CO[C@H]1O[C@H](COS(O)(=O)=O)[C@@H](O[C@@H]2O[C@H]([C@@H](O[C@H]3O[C@H](COS(O)(=O)=O)[C@@H](O[C@@H]4O[C@@H]([C@@H](O[C@H]5O[C@H](COS(O)(=O)=O)[C@@H](O)[C@H](O)[C@H]5NS(O)(=O)=O)[C@H](O)[C@H]4O)C(O)=O)[C@H](OS(O)(=O)=O)[C@H]3NS(O)(=O)=O)[C@H](O)[C@H]2OS(O)(=O)=O)C(O)=O)[C@H](O)[C@H]1NS(O)(=O)=O,Fondaparinux,SmallMoleculeDrug
117,117,pimecrolimus,NDA,2001,pimecrolimus,DB00337,approved; investigational,[H][C@]1(CC[C@H](Cl)[C@@H](C1)OC)\C=C(/C)[C@@]1([H])OC(=O)[C@]2([H])CCCCN2C(=O)C(=O)[C@]2(O)O[C@@]([H])([C@H](C[C@H]2C)OC)[C@H](C[C@@H](C)C\C(C)=C\[C@@H](CC)C(=O)C[C@H](O)[C@H]1C)OC,Pimecrolimus,SmallMoleculeDrug
118,118,desloratadine,NDA,2001,desloratadine,DB00967,approved; investigational,ClC1=CC2=C(C=C1)C(=C1CCNCC1)C1=C(CC2)C=CC=N1,Desloratadine,SmallMoleculeDrug
119,119,nitisinone,NDA,2002,nitisinone,DB00348,approved; investigational,[O-][N+](=O)C1=C(C=CC(=C1)C(F)(F)F)C(=O)C1C(=O)CCCC1=O,Nitisinone,SmallMoleculeDrug
120,120,fulvestrant,NDA,2002,fulvestrant,DB00947,approved; investigational,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=CC=C(O)C=C3C[C@@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)[C@@]21[H],Fulvestrant,SmallMoleculeDrug
121,121,treprostinil sodium,NDA,2002,treprostinil,DB00374,approved; investigational,[H][C@]12C[C@@H](O)[C@H](CC[C@@H](O)CCCCC)[C@@]1([H])CC1=C(C2)C(OCC(O)=O)=CC=C1,Treprostinil,SmallMoleculeDrug
122,122,voriconazole,NDA,2002,voriconazole,DB00582,approved,C[C@@H](C1=NC=NC=C1F)[C@](O)(CN1C=NC=N1)C1=C(F)C=C(F)C=C1,Voriconazole,SmallMoleculeDrug
123,123,tegaserod maleate,NDA,2002,tegaserod,DB01079,approved; investigational; withdrawn,CCCCCNC(=N)N\N=C\C1=CNC2=C1C=C(OC)C=C2,Tegaserod,SmallMoleculeDrug
124,124,oxaliplatin,NDA,2002,oxaliplatin,DB00526,approved; investigational,[H][N]1([H])[C@@H]2CCCC[C@H]2[N]([H])([H])[Pt]11OC(=O)C(=O)O1,Oxaliplatin,SmallMoleculeDrug
125,125,adefovir dipivoxil,NDA,2002,adefovir dipivoxil,DB00718,approved; investigational,CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C(N)N=CN=C12)OCOC(=O)C(C)(C)C,Adefovir dipivoxil,SmallMoleculeDrug
126,126,eplerenone,NDA,2002,eplerenone,DB00700,approved,[H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)C[C@H]1O[C@@]11[C@@]2([H])[C@@H](CC2=CC(=O)CC[C@]12C)C(=O)OC,Eplerenone,SmallMoleculeDrug
127,127,ezetimibe,NDA,2002,ezetimibe,DB00973,approved,[H][C@]1(CC[C@H](O)C2=CC=C(F)C=C2)C(=O)N(C2=CC=C(F)C=C2)[C@]1([H])C1=CC=C(O)C=C1,Ezetimibe,SmallMoleculeDrug
128,128,aripiprazole,NDA,2002,aripiprazole,DB01238,approved; investigational,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,Aripiprazole,SmallMoleculeDrug
129,129,nitazoxanide,NDA,2002,nitazoxanide,DB00507,approved; investigational; vet_approved,CC(=O)OC1=CC=CC=C1C(=O)NC1=NC=C(S1)[N+]([O-])=O,Nitazoxanide,SmallMoleculeDrug
130,130,atomoxetine hydrochloride,NDA,2002,atomoxetine,DB00289,approved,CNCC[C@@H](OC1=CC=CC=C1C)C1=CC=CC=C1,Atomoxetine,SmallMoleculeDrug
131,131,eletriptan hydrobromide,NDA,2002,eletriptan,DB00216,approved; investigational,CN1CCC[C@@H]1CC1=CNC2=C1C=C(CCS(=O)(=O)C1=CC=CC=C1)C=C2,Eletriptan,SmallMoleculeDrug
132,132,aprepitant,NDA,2003,aprepitant,DB00673,approved; investigational,C[C@@H](O[C@H]1OCCN(CC2=NNC(=O)N2)[C@H]1C1=CC=C(F)C=C1)C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F,Aprepitant,SmallMoleculeDrug
133,133,gemifloxacin mesylate,NDA,2003,gemifloxacin,DB01155,approved; investigational,CO\N=C1/CN(CC1CN)C1=NC2=C(C=C1F)C(=O)C(=CN2C1CC1)C(O)=O,Gemifloxacin,SmallMoleculeDrug
134,134,gefitinib,NDA,2003,gefitinib,DB00317,approved; investigational,COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1,Gefitinib,SmallMoleculeDrug
135,135,bortezomib,NDA,2003,bortezomib,DB00188,approved; investigational,CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O,Bortezomib,SmallMoleculeDrug
136,136,alfuzosin hydrochloride,NDA,2003,alfuzosin,DB00346,approved; investigational,COC1=CC2=C(C=C1OC)C(N)=NC(=N2)N(C)CCCNC(=O)C1CCCO1,Alfuzosin,SmallMoleculeDrug
137,137,atazanavir sulfate,NDA,2003,atazanavir,DB01072,approved; investigational,COC(=O)N[C@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@@H](O)CN(CC1=CC=C(C=C1)C1=CC=CC=N1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C,Atazanavir,SmallMoleculeDrug
138,138,emtricitabine,NDA,2003,emtricitabine,DB00879,approved; investigational,NC1=NC(=O)N(C=C1F)[C@@H]1CS[C@H](CO)O1,Emtricitabine,SmallMoleculeDrug
139,139,palonosetron hydrochloride,NDA,2003,palonosetron,DB00377,approved; investigational,[H][C@]12CCCC3=C1C(=CC=C3)C(=O)N(C2)[C@@H]1CN2CCC1CC2,Palonosetron,SmallMoleculeDrug
140,140,miglustat,NDA,2003,miglustat,DB00419,approved,CCCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO,Miglustat,SmallMoleculeDrug
141,141,rosuvastatin calcium,NDA,2003,rosuvastatin,DB01098,approved,CC(C)C1=NC(=NC(C2=CC=C(F)C=C2)=C1\C=C\[C@@H](O)C[C@@H](O)CC(=O)O)N(C)S(C)(=O)=O,Rosuvastatin,SmallMoleculeDrug
142,142,vardenafil hydrochloride,NDA,2003,vardenafil,DB00862,approved,CCCC1=NC(C)=C2N1NC(=NC2=O)C1=C(OCC)C=CC(=C1)S(=O)(=O)N1CCN(CC)CC1,Vardenafil,SmallMoleculeDrug
143,143,daptomycin,NDA,2003,daptomycin,DB00080,approved; investigational,CCCCCCCCCC(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H]1[C@@H](C)OC(=O)[C@H](CC(=O)C2=CC=CC=C2N)NC(=O)[C@@H](NC(=O)[C@@H](CO)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCN)NC(=O)CNC1=O)[C@H](C)CC(O)=O,Daptomycin,SmallMoleculeDrug
144,144,prussian blue,NDA,2003,prussian blue,DB06783,approved,[Fe+3].[Fe+3].[Fe+3].[Fe+3].N#C[Fe-4](C#N)(C#N)(C#N)(C#N)C#N.N#C[Fe-4](C#N)(C#N)(C#N)(C#N)C#N.N#C[Fe-4](C#N)(C#N)(C#N)(C#N)C#N,Prussian blue,SmallMoleculeDrug
145,145,epinastine hydrochloride,NDA,2003,epinastine,DB00751,approved; investigational,NC1=NCC2N1C1=CC=CC=C1CC1=CC=CC=C21,Epinastine,SmallMoleculeDrug
146,146,memantine hydrochloride,NDA,2003,memantine,DB01043,approved; investigational,CC12CC3CC(C)(C1)CC(N)(C3)C2,Memantine,SmallMoleculeDrug
147,147,tadalafil,NDA,2003,tadalafil,DB00820,approved; investigational,[H][C@]12CC3=C(NC4=CC=CC=C34)[C@H](N1C(=O)CN(C)C2=O)C1=CC2=C(OCO2)C=C1,Tadalafil,SmallMoleculeDrug
148,148,abarelix,NDA,2003,abarelix,DB00106,approved; investigational; withdrawn,CC(C)C[C@H](NC(=O)[C@@H](CC(N)=O)NC(=O)[C@H](CC1=CC=C(O)C=C1)N(C)C(=O)[C@H](CO)NC(=O)[C@@H](CC1=CN=CC=C1)NC(=O)[C@@H](CC1=CC=C(Cl)C=C1)NC(=O)[C@@H](CC1=CC2=C(C=CC=C2)C=C1)NC(C)=O)C(=O)N[C@@H](CCCCNC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O,Abarelix,SmallMoleculeDrug
149,149,sertaconazole nitrate,NDA,2003,sertaconazole,DB01153,approved; investigational,ClC1=CC(Cl)=C(C=C1)C(CN1C=CN=C1)OCC1=CSC2=C1C=CC=C2Cl,Sertaconazole,SmallMoleculeDrug
150,150,tiotropium bromide,NDA,2004,tiotropium,DB01409,approved,[H][C@]12O[C@@]1([H])[C@]1([H])C[C@@]([H])(C[C@@]2([H])[N+]1(C)C)OC(=O)C(O)(C1=CC=CS1)C1=CC=CS1,Tiotropium,SmallMoleculeDrug
151,151,pemetrexed disodium,NDA,2004,pemetrexed,DB00642,approved; investigational,NC1=NC(=O)C2=C(NC=C2CCC2=CC=C(C=C2)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N1,Pemetrexed,SmallMoleculeDrug
152,152,cinacalcet hydrochloride,NDA,2004,cinacalcet,DB01012,approved,C[C@@H](NCCCC1=CC(=CC=C1)C(F)(F)F)C1=CC=CC2=CC=CC=C12,Cinacalcet,SmallMoleculeDrug
153,153,telithromycin,NDA,2004,telithromycin,DB00976,approved,[H][C@@]12[C@@H](C)C(=O)[C@H](C)C[C@@](C)(OC)[C@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@@H](C)C(=O)[C@@H](C)C(=O)O[C@H](CC)[C@@]1(C)OC(=O)N2CCCCN1C=NC(=C1)C1=CC=CN=C1,Telithromycin,SmallMoleculeDrug
154,154,apomorphine hydrochloride,NDA,2004,apomorphine,DB00714,approved; investigational,[H][C@]12CC3=C(C(O)=C(O)C=C3)C3=CC=CC(CCN1C)=C23,Apomorphine,SmallMoleculeDrug
155,155,tinidazole,NDA,2004,tinidazole,DB00911,approved; investigational,CCS(=O)(=O)CCN1C(C)=NC=C1[N+]([O-])=O,Tinidazole,SmallMoleculeDrug
156,156,azacitidine,NDA,2004,azacitidine,DB00928,approved; investigational,NC1=NC(=O)N(C=N1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,Azacitidine,SmallMoleculeDrug
157,157,rifaximin,NDA,2004,rifaximin,DB01220,approved; investigational,CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C)C(O)=C4C(O)=C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C1=C(N=C5C=C(C)C=CN15)C4=C3C2=O,Rifaximin,SmallMoleculeDrug
158,158,trospium chloride,NDA,2004,trospium,DB00209,approved,[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(=O)C(O)(C1=CC=CC=C1)C1=CC=CC=C1)[N+]21CCCC1,Trospium,SmallMoleculeDrug
159,159,l-glutamine,NDA,2004,l-glutamine,DB00130,approved; investigational; nutraceutical,N[C@@H](CCC(N)=O)C(O)=O,L-Glutamine,SmallMoleculeDrug
160,160,acamprosate calcium,NDA,2004,acamprosate,DB00659,approved; investigational,CC(=O)NCCCS(O)(=O)=O,Acamprosate,SmallMoleculeDrug
161,161,duloxetine hydrochloride,NDA,2004,duloxetine,DB00476,approved,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,Duloxetine,SmallMoleculeDrug
162,162,erlotinib hydrochloride,NDA,2004,erlotinib,DB00530,approved; investigational,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,Erlotinib,SmallMoleculeDrug
163,163,solifenacin succinate,NDA,2004,solifenacin,DB01591,approved,O=C(O[C@H]1CN2CCC1CC2)N1CCC2=CC=CC=C2[C@@H]1C1=CC=CC=C1,Solifenacin,SmallMoleculeDrug
164,164,eszopiclone,NDA,2004,eszopiclone,DB00402,approved; investigational,CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)C2=NC=CN=C12)C1=NC=C(Cl)C=C1,Eszopiclone,SmallMoleculeDrug
165,165,darifenacin hydrobromide,NDA,2004,darifenacin,DB00496,approved; investigational,NC(=O)C([C@@H]1CCN(CCC2=CC3=C(OCC3)C=C2)C1)(C1=CC=CC=C1)C1=CC=CC=C1,Darifenacin,SmallMoleculeDrug
166,166,ziconotide,NDA,2004,ziconotide,DB06283,approved,[H][C@]12CSSC[C@]3([H])NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CSSC[C@]([H])(NC(=O)[C@]([H])(CSSC[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(N)=N)NC1=O)C(N)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC3=O)C(=O)N[C@@]([H])([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N2,Ziconotide,SmallMoleculeDrug
167,167,iloprost,NDA,2004,iloprost,DB01088,approved; investigational,[H][C@]12C[C@@H](O)[C@H](\C=C\[C@@H](O)C(C)CC#CC)[C@@]1([H])C\C(C2)=C\CCCC(O)=O,Iloprost,SmallMoleculeDrug
168,168,pregabalin,NDA,2004,pregabalin,DB00230,approved; investigational,CC(C)C[C@H](CN)CC(O)=O,Pregabalin,SmallMoleculeDrug
169,169,pramlintide acetate,NDA,2005,pramlintide,DB01278,approved; investigational,[H]N[C@@H](CCCCN)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@@]([H])(NC(=O)[C@H](C)NC(=O)[C@@]([H])(NC(=O)[C@H](CC(N)=O)NC1=O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@]([H])([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@]([H])([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@]([H])([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@]([H])([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(N)=O,Pramlintide,SmallMoleculeDrug
170,170,micafungin sodium,NDA,2005,micafungin,DB01141,approved; investigational,CCCCCOC1=CC=C(C=C1)C1=CC(=NO1)C1=CC=C(C=C1)C(=O)N[C@H]1C[C@@H](O)[C@@H](O)NC(=O)[C@@H]2[C@@H](O)[C@@H](C)CN2C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC1=O)[C@@H](C)O)[C@H](O)[C@@H](O)C1=CC(OS(O)(=O)=O)=C(O)C=C1)[C@H](O)CC(N)=O,Micafungin,SmallMoleculeDrug
171,171,entecavir,NDA,2005,entecavir,DB00442,approved; investigational,NC1=NC(=O)C2=C(N1)N(C=N2)[C@H]1C[C@H](O)[C@@H](CO)C1=C,Entecavir,SmallMoleculeDrug
172,172,tigecycline,NDA,2005,tigecycline,DB00560,approved,[H][C@@]12CC3=C(C(O)=C(NC(=O)CNC(C)(C)C)C=C3N(C)C)C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])C2,Tigecycline,SmallMoleculeDrug
173,173,tipranavir,NDA,2005,tipranavir,DB00932,approved; investigational,[H][C@@](CC)(C1=CC(NS(=O)(=O)C2=NC=C(C=C2)C(F)(F)F)=CC=C1)C1=C(O)C[C@@](CCC)(CCC2=CC=CC=C2)OC1=O,Tipranavir,SmallMoleculeDrug
174,174,ramelteon,NDA,2005,ramelteon,DB00980,approved; investigational,CCC(=O)NCC[C@@H]1CCC2=C1C1=C(OCC1)C=C2,Ramelteon,SmallMoleculeDrug
175,175,nepafenac,NDA,2005,nepafenac,DB06802,approved; investigational,NC(=O)CC1=CC=CC(C(=O)C2=CC=CC=C2)=C1N,Nepafenac,SmallMoleculeDrug
176,176,nelarabine,NDA,2005,nelarabine,DB01280,approved; investigational,COC1=NC(N)=NC2=C1N=CN2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,Nelarabine,SmallMoleculeDrug
177,177,deferasirox,NDA,2005,deferasirox,DB01609,approved; investigational,OC(=O)C1=CC=C(C=C1)N1N=C(N=C1C1=CC=CC=C1O)C1=CC=CC=C1O,Deferasirox,SmallMoleculeDrug
178,178,sorafenib tosylate,NDA,2005,sorafenib,DB00398,approved; investigational,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,Sorafenib,SmallMoleculeDrug
179,179,lenalidomide,NDA,2005,lenalidomide,DB00480,approved,NC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O,Lenalidomide,SmallMoleculeDrug
180,180,conivaptan hydrochloride,NDA,2005,conivaptan,DB00872,approved; investigational,CC1=NC2=C(CCN(C(=O)C3=CC=C(NC(=O)C4=CC=CC=C4C4=CC=CC=C4)C=C3)C3=CC=CC=C23)N1,Conivaptan,SmallMoleculeDrug
181,181,sunitinib malate,NDA,2006,sunitinib,DB01268,approved; investigational,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,Sunitinib,SmallMoleculeDrug
182,182,ranolazine,NDA,2006,ranolazine,DB00243,approved; investigational,COC1=CC=CC=C1OCC(O)CN1CCN(CC(=O)NC2=C(C)C=CC=C2C)CC1,Ranolazine,SmallMoleculeDrug
183,183,lubiprostone,NDA,2006,lubiprostone,DB01046,approved; investigational,[H][C@@]12CC(=O)[C@H](CCCCCCC(O)=O)[C@@]1([H])CC[C@@](O)(O2)C(F)(F)CCCC,Lubiprostone,SmallMoleculeDrug
184,184,anidulafungin,NDA,2006,anidulafungin,DB00362,approved; investigational,[H][C@]1(NC(=O)[C@@H](NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)[C@H](C[C@@H](O)[C@@H](O)NC(=O)[C@@H]2[C@@H](O)[C@@H](C)CN2C1=O)NC(=O)C1=CC=C(C=C1)C1=CC=C(C=C1)C1=CC=C(OCCCCC)C=C1)[C@@H](C)O)[C@H](O)[C@@H](O)C1=CC=C(O)C=C1)[C@@H](C)O,Anidulafungin,SmallMoleculeDrug
185,185,decitabine,NDA,2006,decitabine,DB01262,approved; investigational,NC1=NC(=O)N(C=N1)[C@H]1C[C@H](O)[C@@H](CO)O1,Decitabine,SmallMoleculeDrug
186,186,varenicline,NDA,2006,varenicline,DB01273,approved; investigational,C1C2CNCC1C1=C2C=C2N=CC=NC2=C1,Varenicline,SmallMoleculeDrug
187,187,rasagiline mesylate,NDA,2006,rasagiline,DB01367,approved,C#CCN[C@@H]1CCC2=CC=CC=C12,Rasagiline,SmallMoleculeDrug
188,188,darunavir,NDA,2006,darunavir,DB01264,approved,[H][C@@]12CCO[C@]1([H])OC[C@@H]2OC(=O)N[C@@H](CC1=CC=CC=C1)[C@H](O)CN(CC(C)C)S(=O)(=O)C1=CC=C(N)C=C1,Darunavir,SmallMoleculeDrug
189,189,dasatinib,NDA,2006,dasatinib,DB01254,approved; investigational,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,Dasatinib,SmallMoleculeDrug
190,190,posaconazole,NDA,2006,posaconazole,DB01263,approved; investigational; vet_approved,CC[C@@H]([C@H](C)O)N1N=CN(C1=O)C1=CC=C(C=C1)N1CCN(CC1)C1=CC=C(OC[C@@H]2CO[C@](CN3C=NC=N3)(C2)C2=C(F)C=C(F)C=C2)C=C1,Posaconazole,SmallMoleculeDrug
191,191,vorinostat,NDA,2006,vorinostat,DB02546,approved; investigational,ONC(=O)CCCCCCC(=O)NC1=CC=CC=C1,Vorinostat,SmallMoleculeDrug
192,192,sitagliptin phosphate,NDA,2006,sitagliptin,DB01261,approved; investigational,N[C@@H](CC(=O)N1CCN2C(C1)=NN=C2C(F)(F)F)CC1=CC(F)=C(F)C=C1F,Sitagliptin,SmallMoleculeDrug
193,193,ciclesonide,NDA,2006,ciclesonide,DB01410,approved; investigational,[H][C@@]12C[C@@]3([H])[C@]4([H])CCC5=CC(=O)C=C[C@]5(C)[C@@]4([H])[C@@H](O)C[C@]3(C)[C@@]1(O[C@@H](O2)C1CCCCC1)C(=O)COC(=O)C(C)C,Ciclesonide,SmallMoleculeDrug
194,194,telbivudine,NDA,2006,telbivudine,DB01265,approved; investigational,CC1=CN([C@@H]2C[C@@H](O)[C@H](CO)O2)C(=O)NC1=O,Telbivudine,SmallMoleculeDrug
195,195,paliperidone,NDA,2006,paliperidone,DB01267,approved,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,Paliperidone,SmallMoleculeDrug
196,196,lisdexamfetamine dimesylate,NDA,2007,lisdexamfetamine,DB01255,approved; investigational,C[C@@H](CC1=CC=CC=C1)NC(=O)[C@@H](N)CCCCN,Lisdexamfetamine,SmallMoleculeDrug
197,197,aliskiren,NDA,2007,aliskiren,DB09026,approved; investigational,COCCCOC1=C(OC)C=CC(C[C@@H](C[C@H](N)[C@@H](O)C[C@@H](C(C)C)C(=O)NCC(C)(C)C(N)=O)C(C)C)=C1,Aliskiren,SmallMoleculeDrug
198,198,lapatinib,NDA,2007,lapatinib,DB01259,approved; investigational,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1,Lapatinib,SmallMoleculeDrug
199,199,retapamulin,NDA,2007,retapamulin,DB01256,approved,[H][C@@]12C(=O)CC[C@]11CC[C@@H](C)[C@@]2(C)[C@@H](C[C@@](C)(C=C)[C@@H](O)[C@@H]1C)OC(=O)CS[C@H]1C[C@@H]2CC[C@H](C1)N2C,Retapamulin,SmallMoleculeDrug
200,200,rotigotine,NDA,2007,rotigotine,DB05271,approved,CCCN(CCC1=CC=CS1)[C@H]1CCC2=C(O)C=CC=C2C1,Rotigotine,SmallMoleculeDrug
201,201,temsirolimus,NDA,2007,temsirolimus,DB06287,approved,OCC(C)(CO)C(=O)O[C@@H]1CC[C@@H](C[C@@H](C)[C@]2([H])CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@@H](OC)C[C@]3([H])CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@H]3C(=O)O2)C[C@H]1OC,Temsirolimus,SmallMoleculeDrug
202,202,ambrisentan,NDA,2007,ambrisentan,DB06403,approved; investigational,COC([C@H](OC1=NC(C)=CC(C)=N1)C(O)=O)(C1=CC=CC=C1)C1=CC=CC=C1,Ambrisentan,SmallMoleculeDrug
203,203,maraviroc,NDA,2007,maraviroc,DB04835,approved; investigational,CC(C)C1=NN=C(C)N1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)C1=CC=CC=C1,Maraviroc,SmallMoleculeDrug
204,204,lanreotide,NDA,2007,lanreotide,DB06791,approved,[H]N([H])CCCCC1N([H])C(=O)C(CC2=CN([H])C3=CC=CC=C23)N([H])C(=O)C(CC2=CC=C(O)C=C2)N([H])C(=O)C(CSSCC(N([H])C(=O)C(N([H])C1=O)C(C)C)C(=O)N([H])C(C(C)O)C(=O)N([H])[H])N([H])C(=O)C(CC1=CC2=CC=CC=C2C=C1)N([H])[H],Lanreotide,SmallMoleculeDrug
205,205,doripenem,NDA,2007,doripenem,DB06211,approved; investigational,[H][C@]12[C@@H](C)C(S[C@@H]3CN[C@H](CNS(N)(=O)=O)C3)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(O)=O,Doripenem,SmallMoleculeDrug
206,206,raltegravir,NDA,2007,raltegravir,DB06817,approved,CN1C(=O)C(O)=C(N=C1C(C)(C)NC(=O)C1=NN=C(C)O1)C(=O)NCC1=CC=C(F)C=C1,Raltegravir,SmallMoleculeDrug
207,207,ixabepilone,NDA,2007,ixabepilone,DB04845,approved; investigational,[H][C@]12C[C@H](NC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@@H](O)[C@@H](C)CCC[C@@]1(C)O2)C(\C)=C\C1=CSC(C)=N1,Ixabepilone,SmallMoleculeDrug
208,208,nilotinib,NDA,2007,nilotinib,DB04868,approved; investigational,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,Nilotinib,SmallMoleculeDrug
209,209,sapropterin dihydrochloride,NDA,2007,sapropterin,DB00360,approved; investigational,[H][C@@]1(CNC2=C(N1)C(=O)NC(N)=N2)[C@@H](O)[C@H](C)O,Sapropterin,SmallMoleculeDrug
210,210,nebivolol,NDA,2007,nebivolol,DB04861,approved; investigational,OC(CNCC(O)C1CCC2=C(O1)C=CC(F)=C2)C1CCC2=C(O1)C=CC(F)=C2,Nebivolol,SmallMoleculeDrug
211,211,etravirine,NDA,2008,etravirine,DB06414,approved,CC1=CC(=CC(C)=C1OC1=C(Br)C(N)=NC(NC2=CC=C(C=C2)C#N)=N1)C#N,Etravirine,SmallMoleculeDrug
212,212,desvenlafaxine,NDA,2008,desvenlafaxine,DB06700,approved; investigational,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,Desvenlafaxine,SmallMoleculeDrug
213,213,bendamustine hydrochloride,NDA,2008,bendamustine,DB06769,approved; investigational,CN1C(CCCC(O)=O)=NC2=CC(=CC=C12)N(CCCl)CCCl,Bendamustine,SmallMoleculeDrug
214,214,regadenoson,NDA,2008,regadenoson,DB06213,approved; investigational,CNC(=O)C1=CN(N=C1)C1=NC2=C(N=CN2[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C(N)=N1,Regadenoson,SmallMoleculeDrug
215,215,methylnaltrexoneÂ bromide,NDA,2008,methylnaltrexone,DB06800,approved,C[N@+]1(CC2CC2)CC[C@]23[C@H]4OC5=C(O)C=CC(C[C@@H]1[C@]2(O)CCC4=O)=C35,Methylnaltrexone,SmallMoleculeDrug
216,216,alvimopan,NDA,2008,alvimopan,DB06274,approved; investigational,C[C@H]1CN(C[C@H](CC2=CC=CC=C2)C(=O)NCC(O)=O)CC[C@@]1(C)C1=CC(O)=CC=C1,Alvimopan,SmallMoleculeDrug
217,217,difluprednate,NDA,2008,difluprednate,DB06781,approved,[H][C@@]12CC[C@](OC(=O)CCC)(C(=O)COC(C)=O)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,Difluprednate,SmallMoleculeDrug
218,218,clevidipine,NDA,2008,clevidipine,DB04920,approved; investigational,CCCC(=O)OCOC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC(Cl)=C1Cl)C(=O)OC,Clevidipine,SmallMoleculeDrug
219,219,tetrabenazine,NDA,2008,tetrabenazine,DB04844,approved; investigational,COC1=C(OC)C=C2C3CC(=O)C(CC(C)C)CN3CCC2=C1,Tetrabenazine,SmallMoleculeDrug
220,220,silodosin,NDA,2008,silodosin,DB06207,approved,C[C@H](CC1=CC2=C(N(CCCO)CC2)C(=C1)C(N)=O)NCCOC1=CC=CC=C1OCC(F)(F)F,Silodosin,SmallMoleculeDrug
221,221,lacosamide,NDA,2008,lacosamide,DB06218,approved,COC[C@@H](NC(C)=O)C(=O)NCC1=CC=CC=C1,Lacosamide,SmallMoleculeDrug
222,222,fesoterodine fumarate,NDA,2008,fesoterodine,DB06702,approved,CC(C)N(CC[C@H](C1=CC=CC=C1)C1=C(OC(=O)C(C)C)C=CC(CO)=C1)C(C)C,Fesoterodine,SmallMoleculeDrug
223,223,rufinamide,NDA,2008,rufinamide,DB06201,approved,NC(=O)C1=CN(CC2=C(F)C=CC=C2F)N=N1,Rufinamide,SmallMoleculeDrug
224,224,eltrombopag,NDA,2008,eltrombopag,DB06210,approved,CC1=NN(C(=O)\C1=N/NC1=CC=CC(C2=CC=CC(=C2)C(O)=O)=C1O)C1=CC=C(C)C(C)=C1,Eltrombopag,SmallMoleculeDrug
225,225,tapentadol,NDA,2008,tapentadol,DB06204,approved,CC[C@H]([C@@H](C)CN(C)C)C1=CC(O)=CC=C1,Tapentadol,SmallMoleculeDrug
226,226,fospropofol disodium,NDA,2008,fospropofol,DB06716,approved; illicit; investigational,CC(C)C1=CC=CC(C(C)C)=C1OCOP(O)(O)=O,Fospropofol,SmallMoleculeDrug
227,227,plerixafor,NDA,2008,plerixafor,DB06809,approved,C(N1CCCNCCNCCCNCC1)C1=CC=C(CN2CCCNCCNCCCNCC2)C=C1,Plerixafor,SmallMoleculeDrug
228,228,degarelix,NDA,2008,degarelix,DB06699,approved,CC(C)C[C@H](NC(=O)[C@@H](CC1=CC=C(NC(N)=O)C=C1)NC(=O)[C@H](CC1=CC=C(NC(=O)[C@@H]2CC(=O)NC(=O)N2)C=C1)NC(=O)[C@H](CO)NC(=O)[C@@H](CC1=CC=CN=C1)NC(=O)[C@@H](CC1=CC=C(Cl)C=C1)NC(=O)[C@@H](CC1=CC=C2C=CC=CC2=C1)NC(C)=O)C(=O)N[C@@H](CCCCNC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O,Degarelix,SmallMoleculeDrug
229,229,milnacipran hydrochloride,NDA,2009,milnacipran,DB04896,approved; investigational,CCN(CC)C(=O)C1(CC1CN)C1=CC=CC=C1,Milnacipran,SmallMoleculeDrug
230,230,febuxostat,NDA,2009,febuxostat,DB04854,approved,CC(C)COC1=C(C=C(C=C1)C1=NC(C)=C(S1)C(O)=O)C#N,Febuxostat,SmallMoleculeDrug
231,231,everolimus,NDA,2009,everolimus,DB01590,approved,[H][C@@]1(C[C@@H](C)[C@]2([H])CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@]3([H])CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@@]3([H])C(=O)O2)OC)CC[C@@H](OCCO)[C@@H](C1)OC,Everolimus,SmallMoleculeDrug
232,232,benzyl alcohol,NDA,2009,benzyl alcohol,DB06770,approved,OCC1=CC=CC=C1,Benzyl alcohol,SmallMoleculeDrug
233,233,iloperidone,NDA,2009,iloperidone,DB04946,approved,COC1=C(OCCCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C=CC(=C1)C(C)=O,Iloperidone,SmallMoleculeDrug
234,234,tolvaptan,NDA,2009,tolvaptan,DB06212,approved,CC1=CC=CC=C1C(=O)NC1=CC(C)=C(C=C1)C(=O)N1CCC[C@@H](O)C2=C1C=CC(Cl)=C2,Tolvaptan,SmallMoleculeDrug
235,235,besifloxacin,NDA,2009,besifloxacin,DB06771,approved,N[C@@H]1CCCCN(C1)C1=C(F)C=C2C(=O)C(=CN(C3CC3)C2=C1Cl)C(O)=O,Besifloxacin,SmallMoleculeDrug
236,236,dronedarone,NDA,2009,dronedarone,DB04855,approved,CCCCN(CCCC)CCCOC1=CC=C(C=C1)C(=O)C1=C(CCCC)OC2=C1C=C(NS(C)(=O)=O)C=C2,Dronedarone,SmallMoleculeDrug
237,237,prasugrel,NDA,2009,prasugrel,DB06209,approved,CC(=O)OC1=CC2=C(CCN(C2)C(C(=O)C2CC2)C2=CC=CC=C2F)S1,Prasugrel,SmallMoleculeDrug
238,238,saxagliptin,NDA,2009,saxagliptin,DB06335,approved,[H][C@@]12C[C@]1([H])N([C@@H](C2)C#N)C(=O)[C@@H](N)C12CC3CC(CC(O)(C3)C1)C2,Saxagliptin,SmallMoleculeDrug
239,239,pitavastatin,NDA,2009,pitavastatin,DB08860,approved,O[C@H](C[C@H](O)\C=C\C1=C(N=C2C=CC=CC2=C1C1=CC=C(F)C=C1)C1CC1)CC(O)=O,Pitavastatin,SmallMoleculeDrug
240,240,asenapine,NDA,2009,asenapine,DB06216,approved,CN1CC2C(C1)C1=C(OC3=CC=C(Cl)C=C23)C=CC=C1,Asenapine,SmallMoleculeDrug
241,241,vigabatrin,NDA,2009,vigabatrin,DB01080,approved,NC(CCC(O)=O)C=C,Vigabatrin,SmallMoleculeDrug
242,242,bepotastine besilate,NDA,2009,bepotastine,DB04890,approved,OC(=O)CCCN1CCC(CC1)OC(C1=CC=C(Cl)C=C1)C1=CC=CC=N1,Bepotastine,SmallMoleculeDrug
243,243,telavancin,NDA,2009,telavancin,DB06402,approved,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@@H]2[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]2OC2=C3OC4=CC=C(C=C4Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]4C(C=C2OC2=C(Cl)C=C(C=C2)[C@@H](O)[C@@H]2NC(=O)[C@H](NC4=O)C4=CC(=C(O)C=C4)C4=C(O)C(CNCP(O)(O)=O)=C(O)C=C4[C@H](NC2=O)C(O)=O)=C3)O[C@@H](C)[C@H]1O,Telavancin,SmallMoleculeDrug
244,244,pralatrexate,NDA,2009,pralatrexate,DB06813,approved; investigational,NC1=NC2=NC=C(CC(CC#C)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N=C2C(N)=N1,Pralatrexate,SmallMoleculeDrug
245,245,pazopanib,NDA,2009,pazopanib,DB06589,approved,CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=CC=NC(NC2=CC=C(C)C(=C2)S(N)(=O)=O)=N1,Pazopanib,SmallMoleculeDrug
246,246,romidepsin,NDA,2009,romidepsin,DB06176,approved; investigational,C\C=C1/NC(=O)[C@H]2CSSCC\C=C\[C@H](CC(=O)N[C@H](C(C)C)C(=O)N2)OC(=O)[C@@H](NC1=O)C(C)C,Romidepsin,SmallMoleculeDrug
247,247,capsaicin,NDA,2009,capsaicin,DB06774,approved,COC1=C(O)C=CC(CNC(=O)CCCC\C=C\C(C)C)=C1,Capsaicin,SmallMoleculeDrug
248,248,dalfampridine,NDA,2010,dalfampridine,DB06637,approved,NC1=CC=NC=C1,Dalfampridine,SmallMoleculeDrug
249,249,carglumic acid,NDA,2010,carglumic acid,DB06775,approved,NC(=O)N[C@@H](CCC(O)=O)C(O)=O,Carglumic acid,SmallMoleculeDrug
250,250,polidocanol,NDA,2010,polidocanol,DB06811,approved,CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,Polidocanol,SmallMoleculeDrug
251,251,cabazitaxel,NDA,2010,cabazitaxel,DB06772,approved,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C4=CC=CC=C4)C(C)=C([C@@H](OC)C(=O)[C@]1(C)[C@H](C[C@H]1OC[C@@]21OC(C)=O)OC)C3(C)C,Cabazitaxel,SmallMoleculeDrug
252,252,alcaftadine,NDA,2010,alcaftadine,DB06766,approved,CN1CCC(CC1)=C1C2=NC=C(C=O)N2CCC2=CC=CC=C12,Alcaftadine,SmallMoleculeDrug
253,253,ulipristal acetate,NDA,2010,ulipristal,DB08867,approved,CN(C)C1=CC=C(C=C1)[C@H]1C[C@@]2(C)[C@@H](CC[C@]2(O)C(C)=O)[C@@H]2CCC3=CC(=O)CCC3=C12,Ulipristal,SmallMoleculeDrug
254,254,fingolimod,NDA,2010,fingolimod,DB08868,approved; investigational,CCCCCCCCC1=CC=C(CCC(N)(CO)CO)C=C1,Fingolimod,SmallMoleculeDrug
255,255,dabigatran etexilate mesylate,NDA,2010,dabigatran etexilate,DB06695,approved,CCCCCCOC(=O)\N=C(\N)C1=CC=C(NCC2=NC3=C(C=CC(=C3)C(=O)N(CCC(=O)OCC)C3=NC=CC=C3)N2C)C=C1,Dabigatran etexilate,SmallMoleculeDrug
256,256,lurasidone hydrochloride,NDA,2010,lurasidone,DB08815,approved; investigational,[H][C@@]12[C@H]3CC[C@H](C3)[C@]1([H])C(=O)N(C[C@@H]1CCCC[C@H]1CN1CCN(CC1)C1=NSC3=CC=CC=C13)C2=O,Lurasidone,SmallMoleculeDrug
257,257,ceftaroline fosamil,NDA,2010,ceftaroline fosamil,DB06590,approved; investigational,[H][C@]12SCC(SC3=NC(=CS3)C3=CC=[N+](C)C=C3)=C(N1C(=O)[C@H]2NC(=O)C(=N/OCC)\C1=NSC(NP(O)(O)=O)=N1)C([O-])=O,Ceftaroline fosamil,SmallMoleculeDrug
258,258,eribulin mesylate,NDA,2010,eribulin,DB08871,approved; investigational,[H][C@@]12CC(=C)[C@]([H])(CC[C@@]3([H])C[C@@H](C)C(=C)[C@@]([H])(C[C@]4([H])O[C@H](C[C@H](O)CN)[C@H](OC)[C@@]4([H])CC(=O)C[C@@]4([H])CC[C@]5([H])O[C@@]6([H])[C@H]7O[C@@]8(C[C@]7([H])O[C@@]6([H])[C@@]([H])(O8)[C@@]5([H])O4)CC1)O3)O2,Eribulin,SmallMoleculeDrug
259,259,spinosad,NDA,2011,spinosad,DB08823,approved; investigational; vet_approved,[H][C@]1(C[C@@]2([H])C=C[C@@]3([H])[C@]4([H])CC(=O)O[C@@]([H])(CC)CCC[C@]([H])(O[C@@]5([H])CC[C@]([H])(N(C)C)[C@@]([H])(C)O5)[C@@]([H])(C)C(=O)C4=C[C@@]3([H])[C@]2([H])C1)O[C@]1([H])O[C@@]([H])(C)[C@]([H])(OC)[C@@]([H])(OC)[C@@]1([H])OC.[H][C@]1(C[C@@]2([H])C(C)=C[C@@]3([H])[C@]4([H])CC(=O)O[C@@]([H])(CC)CCC[C@]([H])(O[C@@]5([H])CC[C@]([H])(N(C)C)[C@@]([H])(C)O5)[C@@]([H])(C)C(=O)C4=C[C@@]3([H])[C@]2([H])C1)O[C@]1([H])O[C@@]([H])(C)[C@]([H])(OC)[C@@]([H])(OC)[C@@]1([H])OC,Spinosad,SmallMoleculeDrug
260,260,vilazodone hydrochloride,NDA,2011,vilazodone,DB06684,approved,NC(=O)C1=CC2=CC(=CC=C2O1)N1CCN(CCCCC2=CNC3=C2C=C(C=C3)C#N)CC1,Vilazodone,SmallMoleculeDrug
261,261,azilsartan medoxomil,NDA,2011,azilsartan medoxomil,DB08822,approved; investigational,CCOC1=NC2=C(N1CC1=CC=C(C=C1)C1=CC=CC=C1C1=NOC(=O)N1)C(=CC=C2)C(=O)OCC1=C(C)OC(=O)O1,Azilsartan medoxomil,SmallMoleculeDrug
262,262,roflumilast,NDA,2011,roflumilast,DB01656,approved,FC(F)OC1=C(OCC2CC2)C=C(C=C1)C(=O)NC1=C(Cl)C=NC=C1Cl,Roflumilast,SmallMoleculeDrug
263,263,gadobutrol,NDA,2011,gadobutrol,DB06703,approved,OC[C@H](O)[C@H](CO)[N+]12CC[N+]3(CC([O-])=O)CC[N+]4(CC([O-])=O)CC[N+](CC([O-])=O)(CC1)[Gd-]234,Gadobutrol,SmallMoleculeDrug
264,264,gabapentin enacarbil,NDA,2011,gabapentin enacarbil,DB08872,approved; investigational,CC(C)C(=O)OC(C)OC(=O)NCC1(CC(O)=O)CCCCC1,Gabapentin enacarbil,SmallMoleculeDrug
265,265,abiraterone acetate,NDA,2011,abiraterone,DB05812,approved,[H][C@@]12CC=C(C3=CC=CN=C3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@H](O)CC[C@]12C,Abiraterone,SmallMoleculeDrug
266,266,linagliptin,NDA,2011,linagliptin,DB08882,approved,CC#CCN1C(=NC2=C1C(=O)N(CC1=NC3=C(C=CC=C3)C(C)=N1)C(=O)N2C)N1CCC[C@@H](N)C1,Linagliptin,SmallMoleculeDrug
267,267,boceprevir,NDA,2011,boceprevir,DB08873,approved; withdrawn,[H][C@]12CN([C@H](C(=O)NC(CC3CCC3)C(=O)C(N)=O)[C@@]1([H])C2(C)C)C(=O)[C@@H](NC(=O)NC(C)(C)C)C(C)(C)C,Boceprevir,SmallMoleculeDrug
268,268,rilpivirine,NDA,2011,rilpivirine,DB08864,approved,CC1=CC(\C=C\C#N)=CC(C)=C1NC1=CC=NC(NC2=CC=C(C=C2)C#N)=N1,Rilpivirine,SmallMoleculeDrug
269,269,telaprevir,NDA,2011,telaprevir,DB05521,approved; withdrawn,[H][C@@]12CCC[C@]1([H])[C@H](N(C2)C(=O)[C@@H](NC(=O)[C@@H](NC(=O)C1=NC=CN=C1)C1CCCCC1)C(C)(C)C)C(=O)N[C@@H](CCC)C(=O)C(=O)NC1CC1,Telaprevir,SmallMoleculeDrug
270,270,fidaxomicin,NDA,2011,fidaxomicin,DB08874,approved,[H][C@@]1(O[C@@H]2[C@@H](CC)\C=C(C)\[C@@H](O)C\C=C\C=C(CO[C@@H]3O[C@H](C)[C@@H](OC(=O)C4=C(CC)C(Cl)=C(O)C(Cl)=C4O)[C@H](O)[C@@H]3OC)\C(=O)O[C@@H](C\C=C(/C)\C=C2/C)[C@@H](C)O)OC(C)(C)[C@@H](OC(=O)C(C)C)[C@H](O)[C@@H]1O,Fidaxomicin,SmallMoleculeDrug
271,271,ezogabine,NDA,2011,ezogabine,DB04953,approved; investigational,CCOC(=O)NC1=C(N)C=C(NCC2=CC=C(F)C=C2)C=C1,Ezogabine,SmallMoleculeDrug
272,272,indacaterol,NDA,2011,indacaterol,DB05039,approved,CCC1=C(CC)C=C2CC(CC2=C1)NC[C@H](O)C1=C2C=CC(=O)NC2=C(O)C=C1,Indacaterol,SmallMoleculeDrug
273,273,rivaroxaban,NDA,2011,rivaroxaban,DB06228,approved,ClC1=CC=C(S1)C(=O)NC[C@H]1CN(C(=O)O1)C1=CC=C(C=C1)N1CCOCC1=O,Rivaroxaban,SmallMoleculeDrug
274,274,ticagrelor,NDA,2011,ticagrelor,DB08816,approved,CCCSC1=NC2=C(N=NN2[C@@H]2C[C@H](OCCO)[C@@H](O)[C@H]2O)C(N[C@@H]2C[C@H]2C2=CC(F)=C(F)C=C2)=N1,Ticagrelor,SmallMoleculeDrug
275,275,vemurafenib,NDA,2011,vemurafenib,DB08881,approved,CCCS(=O)(=O)NC1=C(F)C(C(=O)C2=CNC3=NC=C(C=C23)C2=CC=C(Cl)C=C2)=C(F)C=C1,Vemurafenib,SmallMoleculeDrug
276,276,icatibant,NDA,2011,icatibant,DB06196,approved; investigational,[H][C@]12C[C@]([H])(N(C(=O)[C@@]3([H])CC4=C(CN3C(=O)[C@H](CO)NC(=O)[C@H](CC3=CC=CS3)NC(=O)CNC(=O)[C@]3([H])C[C@@H](O)CN3C(=O)[C@@H]3CCCN3C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](N)CCCNC(N)=N)C=CC=C4)[C@@]1([H])CCCC2)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O,Icatibant,SmallMoleculeDrug
277,277,crizotinib,NDA,2011,crizotinib,DB08865,approved,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Crizotinib,SmallMoleculeDrug
278,278,deferiprone,NDA,2011,deferiprone,DB08826,approved,CN1C=CC(=O)C(O)=C1C,Deferiprone,SmallMoleculeDrug
279,279,clobazam,NDA,2011,clobazam,DB00349,approved; illicit,CN1C2=C(C=C(Cl)C=C2)N(C2=CC=CC=C2)C(=O)CC1=O,Clobazam,SmallMoleculeDrug
280,280,ruxolitinib,NDA,2011,ruxolitinib,DB08877,approved,N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1,Ruxolitinib,SmallMoleculeDrug
281,281,ingenol mebutate,NDA,2012,ingenol mebutate,DB05013,approved,[H][C@@]12C[C@@H](C)[C@]34C=C(C)[C@H](OC(=O)C(\C)=C/C)[C@@]3(O)[C@H](O)C(CO)=C[C@@]([H])(C4=O)[C@]1([H])C2(C)C,Ingenol mebutate,SmallMoleculeDrug
282,282,axitinib,NDA,2012,axitinib,DB06626,approved; investigational,CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1,Axitinib,SmallMoleculeDrug
283,283,vismodegib,NDA,2012,vismodegib,DB08828,approved; investigational,CS(=O)(=O)C1=CC(Cl)=C(C=C1)C(=O)NC1=CC=C(Cl)C(=C1)C1=CC=CC=N1,Vismodegib,SmallMoleculeDrug
284,284,ivacaftor,NDA,2012,ivacaftor,DB08820,approved,CC(C)(C)C1=CC(=C(O)C=C1NC(=O)C1=CNC2=CC=CC=C2C1=O)C(C)(C)C,Ivacaftor,SmallMoleculeDrug
285,285,tafluprost,NDA,2012,tafluprost,DB08819,approved,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\C(F)(F)COC1=CC=CC=C1,Tafluprost,SmallMoleculeDrug
286,286,avanafil,NDA,2012,avanafil,DB06237,approved,COC1=C(Cl)C=C(CNC2=C(C=NC(=N2)N2CCC[C@H]2CO)C(=O)NCC2=NC=CC=N2)C=C1,Avanafil,SmallMoleculeDrug
287,287,lorcaserin hydrochloride,NDA,2012,lorcaserin,DB04871,approved,C[C@H]1CNCCC2=CC=C(Cl)C=C12,Lorcaserin,SmallMoleculeDrug
288,288,mirabegron,NDA,2012,mirabegron,DB08893,approved,NC1=NC(CC(=O)NC2=CC=C(CCNC[C@H](O)C3=CC=CC=C3)C=C2)=CS1,Mirabegron,SmallMoleculeDrug
289,289,carfilzomib,NDA,2012,carfilzomib,DB08889,approved; investigational,CC(C)C[C@H](NC(=O)[C@H](CCC1=CC=CC=C1)NC(=O)CN1CCOCC1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]1(C)CO1,Carfilzomib,SmallMoleculeDrug
290,290,aclidinium bromide,NDA,2012,aclidinium,DB08897,approved,OC(C(=O)O[C@H]1C[N+]2(CCCOC3=CC=CC=C3)CCC1CC2)(C1=CC=CS1)C1=CC=CS1,Aclidinium,SmallMoleculeDrug
291,291,linaclotide,NDA,2012,linaclotide,DB08890,approved,[H][C@]1(CSSC[C@]2([H])NC(=O)[C@H](CC3=CC=C(O)C=C3)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]3CSSC[C@H](NC(=O)[C@H](C)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CSSC[C@H](N)C(=O)N3)NC2=O)C(=O)N[C@@]([H])([C@@H](C)O)C(=O)NCC(=O)N1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O,Linaclotide,SmallMoleculeDrug
292,292,enzalutamide,NDA,2012,enzalutamide,DB08899,approved,CNC(=O)C1=C(F)C=C(C=C1)N1C(=S)N(C(=O)C1(C)C)C1=CC=C(C#N)C(=C1)C(F)(F)F,Enzalutamide,SmallMoleculeDrug
293,293,bosutinib,NDA,2012,bosutinib,DB06616,approved,COC1=CC(NC2=C(C=NC3=CC(OCCCN4CCN(C)CC4)=C(OC)C=C23)C#N)=C(Cl)C=C1Cl,Bosutinib,SmallMoleculeDrug
294,294,teriflunomide,NDA,2012,teriflunomide,DB08880,approved,C\C(O)=C(/C#N)C(=O)NC1=CC=C(C=C1)C(F)(F)F,Teriflunomide,SmallMoleculeDrug
295,295,regorafenib,NDA,2012,regorafenib,DB08896,approved,CNC(=O)C1=CC(OC2=CC(F)=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1,Regorafenib,SmallMoleculeDrug
296,296,perampanel,NDA,2012,perampanel,DB08883,approved,O=C1N(C=C(C=C1C1=CC=CC=C1C#N)C1=NC=CC=C1)C1=CC=CC=C1,Perampanel,SmallMoleculeDrug
297,297,tofacitinib,NDA,2012,tofacitinib,DB08895,approved; investigational,C[C@@H]1CCN(C[C@@H]1N(C)C1=NC=NC2=C1C=CN2)C(=O)CC#N,Tofacitinib,SmallMoleculeDrug
298,298,cabozantinib,NDA,2012,cabozantinib,DB08875,approved; investigational,COC1=CC2=C(C=C1OC)C(OC1=CC=C(NC(=O)C3(CC3)C(=O)NC3=CC=C(F)C=C3)C=C1)=CC=N2,Cabozantinib,SmallMoleculeDrug
299,299,pasireotide,NDA,2012,pasireotide,DB06663,approved,NCCCC[C@@H]1NC(=O)[C@@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@@H](NC(=O)[C@@H]2C[C@H](CN2C(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(OCC3=CC=CC=C3)C=C2)NC1=O)OC(=O)NCCN)C1=CC=CC=C1,Pasireotide,SmallMoleculeDrug
300,300,ponatinib,NDA,2012,ponatinib,DB08901,approved; investigational,CN1CCN(CC2=CC=C(NC(=O)C3=CC(C#CC4=CN=C5C=CC=NN45)=C(C)C=C3)C=C2C(F)(F)F)CC1,Ponatinib,SmallMoleculeDrug
301,301,lomitapide,NDA,2012,lomitapide,DB08827,approved; investigational,FC(F)(F)CNC(=O)C1(CCCCN2CCC(CC2)NC(=O)C2=C(C=CC=C2)C2=CC=C(C=C2)C(F)(F)F)C2=CC=CC=C2C2=CC=CC=C12,Lomitapide,SmallMoleculeDrug
302,302,apixaban,NDA,2012,apixaban,DB06605,approved,COC1=CC=C(C=C1)N1N=C(C(N)=O)C2=C1C(=O)N(CC2)C1=CC=C(C=C1)N1CCCCC1=O,Apixaban,SmallMoleculeDrug
303,303,bedaquiline,NDA,2012,bedaquiline,DB08903,approved,COC1=NC2=C(C=C(Br)C=C2)C=C1[C@@H](C1=CC=CC=C1)[C@@](O)(CCN(C)C)C1=CC=CC2=C1C=CC=C2,Bedaquiline,SmallMoleculeDrug
304,304,alogliptin,NDA,2013,alogliptin,DB06203,approved,CN1C(=O)C=C(N2CCC[C@@H](N)C2)N(CC2=C(C=CC=C2)C#N)C1=O,Alogliptin,SmallMoleculeDrug
305,305,mipomersen sodium,NDA,2013,mipomersen,DB05528,approved; investigational,COCCO[C@H]1[C@@H](O)[C@H](COP(O)(=O)S[C@H]2[C@H](COP(O)(=O)S[C@H]3[C@H](COP(O)(=O)S[C@H]4[C@H](COP(O)(=O)S[C@@H]5[C@@H](COP(O)(=O)S[C@H]6C[C@@H](O[C@@H]6COP(O)(=O)S[C@H]6C[C@@H](O[C@@H]6COP(O)(=O)S[C@H]6C[C@@H](O[C@@H]6COP(O)(=O)S[C@H]6C[C@@H](O[C@@H]6COP(O)(=O)S[C@H]6C[C@@H](O[C@@H]6COP(O)(=O)S[C@H]6C[C@@H](O[C@@H]6COP(O)(=O)S[C@H]6C[C@@H](O[C@@H]6COP(O)(=O)S[C@H]6C[C@@H](O[C@@H]6COP(O)(=O)S[C@H]6C[C@@H](O[C@@H]6COP(O)(=O)S[C@H]6C[C@@H](O[C@@H]6COP(O)(=O)S[C@@H]6[C@@H](COP(O)(=O)S[C@@H]7[C@@H](COP(O)(=O)S[C@@H]8[C@@H](COP(O)(=O)S[C@@H]9[C@@H](COP(O)(=O)S[C@@H]%10[C@@H](CO)O[C@H]([C@@H]%10OCCOC)N%10C=NC%11=C%10N=C(N)NC%11=O)O[C@H]([C@@H]9OCCOC)N9C=C(C)C(N)=NC9=O)O[C@H]([C@@H]8OCCOC)N8C=C(C)C(N)=NC8=O)O[C@H]([C@@H]7OCCOC)N7C=C(C)C(=O)NC7=O)O[C@H]([C@@H]6OCCOC)N6C=C(C)C(N)=NC6=O)N6C=NC7=C6N=CN=C7N)N6C=NC7=C6N=C(N)NC7=O)N6C=C(C)C(=O)NC6=O)N6C=C(C)C(N)=NC6=O)N6C=C(C)C(=O)NC6=O)N6C=NC7=C6N=C(N)NC7=O)N6C=C(C)C(N)=NC6=O)N6C=C(C)C(=O)NC6=O)N6C=C(C)C(=O)NC6=O)N6C=C(C)C(N)=NC6=O)O[C@H]([C@@H]5OCCOC)N5C=NC6=C5N=C(N)NC6=O)O[C@@H]([C@H]4OCCOC)N4C=C(C)C(N)=NC4=O)O[C@@H]([C@H]3OCCOC)N3C=NC4=C3N=CN=C4N)O[C@@H]([C@H]2OCCOC)N2C=C(C)C(N)=NC2=O)O[C@@H]1N1C=C(C)C(N)=NC1=O,Mipomersen,SmallMoleculeDrug
306,306,pomalidomide,NDA,2013,pomalidomide,DB08910,approved,NC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O,Pomalidomide,SmallMoleculeDrug
307,307,ospemifene,NDA,2013,ospemifene,DB04938,approved; investigational,OCCOC1=CC=C(C=C1)C(=C(\CCCl)C1=CC=CC=C1)\C1=CC=CC=C1,Ospemifene,SmallMoleculeDrug
308,308,canagliflozin,NDA,2013,canagliflozin,DB08907,approved,[H][C@]1(O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)C1=CC=C(C)C(CC2=CC=C(S2)C2=CC=C(F)C=C2)=C1,Canagliflozin,SmallMoleculeDrug
309,309,dabrafenib,NDA,2013,dabrafenib,DB08912,approved; investigational,CC(C)(C)C1=NC(=C(S1)C1=NC(N)=NC=C1)C1=C(F)C(NS(=O)(=O)C2=C(F)C=CC=C2F)=CC=C1,Dabrafenib,SmallMoleculeDrug
310,310,trametinib,NDA,2013,trametinib,DB08911,approved,CN1C(=O)C(C)=C2N(C(=O)N(C3CC3)C(=O)C2=C1NC1=CC=C(I)C=C1F)C1=CC(NC(C)=O)=CC=C1,Trametinib,SmallMoleculeDrug
311,311,afatinib,NDA,2013,afatinib,DB08916,approved,CN(C)C\C=C\C(=O)NC1=C(O[C@H]2CCOC2)C=C2N=CN=C(NC3=CC(Cl)=C(F)C=C3)C2=C1,Afatinib,SmallMoleculeDrug
312,312,dolutegravir,NDA,2013,dolutegravir,DB08930,approved,[H][C@]12CN3C=C(C(=O)NCC4=CC=C(F)C=C4F)C(=O)C(O)=C3C(=O)N1[C@H](C)CCO2,Dolutegravir,SmallMoleculeDrug
313,313,vortioxetine,NDA,2013,vortioxetine,DB09068,approved; investigational,CC1=CC=C(SC2=CC=CC=C2N2CCNCC2)C(C)=C1,Vortioxetine,SmallMoleculeDrug
314,314,riociguat,NDA,2013,riociguat,DB08931,approved,COC(=O)N(C)C1=C(N)N=C(N=C1N)C1=NN(CC2=C(F)C=CC=C2)C2=C1C=CC=N2,Riociguat,SmallMoleculeDrug
315,315,macitentan,NDA,2013,macitentan,DB08932,approved,CCCNS(=O)(=O)NC1=C(C(OCCOC2=NC=C(Br)C=N2)=NC=N1)C1=CC=C(Br)C=C1,Macitentan,SmallMoleculeDrug
316,316,eslicarbazepine acetate,NDA,2013,eslicarbazepine,DB14575,approved,NC(=O)N1C2=C(C[C@H](O)C3=C1C=CC=C3)C=CC=C2,Eslicarbazepine,SmallMoleculeDrug
317,317,ibrutinib,NDA,2013,ibrutinib,DB09053,approved,NC1=NC=NC2=C1C(=NN2[C@@H]1CCCN(C1)C(=O)C=C)C1=CC=C(OC2=CC=CC=C2)C=C1,Ibrutinib,SmallMoleculeDrug
318,318,luliconazole,NDA,2013,luliconazole,DB08933,approved,ClC1=CC(Cl)=C(C=C1)[C@@H]1CS\C(S1)=C(\C#N)N1C=CN=C1,Luliconazole,SmallMoleculeDrug
319,319,simeprevir,NDA,2013,simeprevir,DB06290,approved,[H][C@]12C[C@]1(NC(=O)[C@]1([H])C[C@H](C[C@@]1([H])C(=O)N(C)CCCC\C=C/2)OC1=CC(=NC2=C1C=CC(OC)=C2C)C1=NC(=CS1)C(C)C)C(=O)NS(=O)(=O)C1CC1,Simeprevir,SmallMoleculeDrug
320,320,sofosbuvir,NDA,2013,sofosbuvir,DB08934,approved,CC(C)OC(=O)[C@H](C)N[P@](=O)(OC[C@H]1O[C@@H](N2C=CC(=O)NC2=O)[C@](C)(F)[C@@H]1O)OC1=CC=CC=C1,Sofosbuvir,SmallMoleculeDrug
321,321,dapagliflozin,NDA,2014,dapagliflozin,DB06292,approved,CCOC1=CC=C(CC2=C(Cl)C=CC(=C2)[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C=C1,Dapagliflozin,SmallMoleculeDrug
322,322,tasimelteon,NDA,2014,tasimelteon,DB09071,approved; investigational,CCC(=O)NC[C@@H]1C[C@H]1C1=CC=CC2=C1CCO2,Tasimelteon,SmallMoleculeDrug
323,323,droxidopa,NDA,2014,droxidopa,DB06262,approved; investigational,N[C@@H]([C@H](O)C1=CC(O)=C(O)C=C1)C(O)=O,Droxidopa,SmallMoleculeDrug
324,324,miltefosine,NDA,2014,miltefosine,DB09031,approved; investigational,CCCCCCCCCCCCCCCCOP([O-])(=O)OCC[N+](C)(C)C,Miltefosine,SmallMoleculeDrug
325,325,apremilast,NDA,2014,apremilast,DB05676,approved; investigational,CCOC1=CC(=CC=C1OC)[C@@H](CS(C)(=O)=O)N1C(=O)C2=CC=CC(NC(C)=O)=C2C1=O,Apremilast,SmallMoleculeDrug
326,326,ceritinib,NDA,2014,ceritinib,DB09063,approved,CC(C)OC1=C(NC2=NC=C(Cl)C(N2)=NC2=CC=CC=C2S(=O)(=O)C(C)C)C=C(C)C(=C1)C1CCNCC1,Ceritinib,SmallMoleculeDrug
327,327,vorapaxar,NDA,2014,vorapaxar,DB09030,approved,[H][C@@]12C[C@]3([H])C[C@@H](CC[C@@]3([H])[C@H](\C=C\C3=CC=C(C=N3)C3=CC(F)=CC=C3)[C@]1([H])[C@@H](C)OC2=O)NC(=O)OCC,Vorapaxar,SmallMoleculeDrug
328,328,efinaconazole,NDA,2014,efinaconazole,DB09040,approved,C[C@@H](N1CCC(=C)CC1)[C@](O)(CN1C=NC=N1)C1=C(F)C=C(F)C=C1,Efinaconazole,SmallMoleculeDrug
329,329,tedizolid phosphate,NDA,2014,tedizolid,DB14569,approved; investigational,CN1N=NC(=N1)C1=NC=C(C=C1)C1=C(F)C=C(C=C1)N1C[C@H](CO)OC1=O,Tedizolid,SmallMoleculeDrug
330,330,belinostat,NDA,2014,belinostat,DB05015,approved; investigational,ONC(=O)\C=C\C1=CC=CC(=C1)S(=O)(=O)NC1=CC=CC=C1,Belinostat,SmallMoleculeDrug
331,331,tavaborole,NDA,2014,tavaborole,DB09041,approved; investigational,OB1OCC2=CC(F)=CC=C12,Tavaborole,SmallMoleculeDrug
332,332,idelalisib,NDA,2014,idelalisib,DB09054,approved,[H][C@@](CC)(NC1=NC=NC2=C1N=CN2)C1=NC2=CC=CC(F)=C2C(=O)N1C1=CC=CC=C1,Idelalisib,SmallMoleculeDrug
333,333,olodaterol,NDA,2014,olodaterol,DB09080,approved,COC1=CC=C(CC(C)(C)NC[C@H](O)C2=C3OCC(=O)NC3=CC(O)=C2)C=C1,Olodaterol,SmallMoleculeDrug
334,334,empagliflozin,NDA,2014,empagliflozin,DB09038,approved,OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)C1=CC=C(Cl)C(CC2=CC=C(O[C@H]3CCOC3)C=C2)=C1,Empagliflozin,SmallMoleculeDrug
335,335,oritavancin diphosphate,NDA,2014,oritavancin,DB04911,approved; investigational,CN[C@H](CC(C)C)C(=O)N[C@@H]1[C@H](O)C2=CC=C(OC3=C(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@H]4C[C@](C)(NCC5=CC=C(C=C5)C5=CC=C(Cl)C=C5)[C@@H](O)[C@H](C)O4)C4=CC(=C3)[C@@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N[C@@H]1C3=CC(=C(O)C=C3)C3=C(O)C=C(O)C=C3[C@H](NC(=O)[C@@H](NC1=O)[C@H](O[C@H]1C[C@](C)(N)[C@@H](O)[C@H](C)O1)C1=CC(Cl)=C(O4)C=C1)C(O)=O)C(Cl)=C2,Oritavancin,SmallMoleculeDrug
336,336,suvorexant,NDA,2014,suvorexant,DB09034,approved; investigational,[H][C@@]1(C)CCN(CCN1C(=O)C1=C(C=CC(C)=C1)N1N=CC=N1)C1=NC2=C(O1)C=CC(Cl)=C2,Suvorexant,SmallMoleculeDrug
337,337,eliglustat,NDA,2014,eliglustat,DB09039,approved,CCCCCCCC(=O)N[C@H](CN1CCCC1)[C@H](O)C1=CC=C2OCCOC2=C1,Eliglustat,SmallMoleculeDrug
338,338,naloxegol,NDA,2014,naloxegol,DB09049,approved,COCCOCCOCCOCCOCCOCCOCCO[C@H]1CC[C@@]2(O)[C@H]3CC4=CC=C(O)C5=C4[C@@]2(CCN3CC=C)[C@H]1O5,Naloxegol,SmallMoleculeDrug
339,339,pirfenidone,NDA,2014,pirfenidone,DB04951,approved; investigational,CC1=CN(C(=O)C=C1)C1=CC=CC=C1,Pirfenidone,SmallMoleculeDrug
340,340,nintedanib,NDA,2014,nintedanib,DB09079,approved,COC(=O)C1=CC=C2C(NC(=O)\C2=C(/NC2=CC=C(C=C2)N(C)C(=O)CN2CCN(C)CC2)C2=CC=CC=C2)=C1,Nintedanib,SmallMoleculeDrug
341,341,finafloxacin,NDA,2014,finafloxacin,DB09047,approved; investigational,[H][C@]12CN(C[C@]1([H])OCCN2)C1=C(F)C=C2C(=O)C(=CN(C3CC3)C2=C1C#N)C(O)=O,Finafloxacin,SmallMoleculeDrug
342,342,olaparib,NDA,2014,olaparib,DB09074,approved,FC1=CC=C(CC2=NNC(=O)C3=CC=CC=C23)C=C1C(=O)N1CCN(CC1)C(=O)C1CC1,Olaparib,SmallMoleculeDrug
343,343,peramivir,NDA,2014,peramivir,DB06614,approved; investigational,[H][C@@]1([C@@H](NC(C)=O)C(CC)CC)[C@H](O)[C@H](C[C@H]1NC(N)=N)C(O)=O,Peramivir,SmallMoleculeDrug
344,344,edoxaban tosylate,NDA,2015,edoxaban,DB09075,approved,CN(C)C(=O)[C@H]1CC[C@H](NC(=O)C(=O)NC2=NC=C(Cl)C=C2)[C@@H](C1)NC(=O)C1=NC2=C(CN(C)CC2)S1,Edoxaban,SmallMoleculeDrug
345,345,palbociclib,NDA,2015,palbociclib,DB09073,approved; investigational,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O,Palbociclib,SmallMoleculeDrug
346,346,lenvatinib,NDA,2015,lenvatinib,DB09078,approved; investigational,COC1=C(C=C2C(OC3=CC=C(NC(=O)NC4CC4)C(Cl)=C3)=CC=NC2=C1)C(N)=O,Lenvatinib,SmallMoleculeDrug
347,347,panobinostat,NDA,2015,panobinostat,DB06603,approved; investigational,CC1=C(CCNCC2=CC=C(\C=C\C(=O)NO)C=C2)C2=CC=CC=C2N1,Panobinostat,SmallMoleculeDrug
348,348,isavuconazonium sulfate,NDA,2015,isavuconazonium,DB06636,approved; investigational,[H]C(C)(OC(=O)N(C)C1=C(COC(=O)CNC)C=CC=N1)[N+]1=CN(C[C@](O)(C2=C(F)C=CC(F)=C2)[C@@]([H])(C)C2=NC(=CS2)C2=CC=C(C=C2)C#N)N=C1,Isavuconazonium,SmallMoleculeDrug
349,349,cholic acid,NDA,2015,cholic acid,DB02659,approved,[H][C@@](C)(CCC(O)=O)[C@@]1([H])CC[C@@]2([H])[C@]3([H])[C@]([H])(O)C[C@]4([H])C[C@]([H])(O)CC[C@]4(C)[C@@]3([H])C[C@]([H])(O)[C@]12C,Cholic Acid,SmallMoleculeDrug
350,350,ivabradine,NDA,2015,ivabradine,DB09083,approved,COC1=C(OC)C=C2[C@@H](CN(C)CCCN3CCC4=CC(OC)=C(OC)C=C4CC3=O)CC2=C1,Ivabradine,SmallMoleculeDrug
351,351,deoxycholic acid,NDA,2015,deoxycholic acid,DB03619,approved,[H][C@@]12CC[C@H]([C@H](C)CCC(O)=O)[C@@]1(C)[C@@H](O)C[C@@]1([H])[C@@]2([H])CC[C@]2([H])C[C@H](O)CC[C@]12C,Deoxycholic acid,SmallMoleculeDrug
352,352,eluxadoline,NDA,2015,eluxadoline,DB09272,approved; investigational,COC1=CC=C(CN([C@@H](C)C2=NC(=CN2)C2=CC=CC=C2)C(=O)[C@@H](N)CC2=C(C)C=C(C=C2C)C(N)=O)C=C1C(O)=O,Eluxadoline,SmallMoleculeDrug
353,353,cangrelor,NDA,2015,cangrelor,DB06441,approved,CSCCNC1=C2N=CN([C@@H]3O[C@H](COP(O)(=O)OP(O)(=O)C(Cl)(Cl)P(O)(O)=O)[C@@H](O)[C@H]3O)C2=NC(SCCC(F)(F)F)=N1,Cangrelor,SmallMoleculeDrug
354,354,brexpiprazole,NDA,2015,brexpiprazole,DB09128,approved; investigational,O=C1NC2=CC(OCCCCN3CCN(CC3)C3=C4C=CSC4=CC=C3)=CC=C2C=C1,Brexpiprazole,SmallMoleculeDrug
355,355,sonidegib,NDA,2015,sonidegib,DB09143,approved; investigational,[H][C@]1(C)CN(C[C@@]([H])(C)O1)C1=CC=C(NC(=O)C2=CC=CC(=C2C)C2=CC=C(OC(F)(F)F)C=C2)C=N1,Sonidegib,SmallMoleculeDrug
356,356,daclatasvir,NDA,2015,daclatasvir,DB09102,approved; investigational,COC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C1=NC=C(N1)C1=CC=C(C=C1)C1=CC=C(C=C1)C1=CN=C(N1)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)OC)C(C)C,Daclatasvir,SmallMoleculeDrug
357,357,flibanserin,NDA,2015,flibanserin,DB04908,approved; investigational,FC(F)(F)C1=CC(=CC=C1)N1CCN(CCN2C(=O)NC3=CC=CC=C23)CC1,Flibanserin,SmallMoleculeDrug
358,358,rolapitant,NDA,2015,rolapitant,DB09291,approved; investigational,C[C@@H](OC[C@]1(CC[C@]2(CCC(=O)N2)CN1)C1=CC=CC=C1)C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F,Rolapitant,SmallMoleculeDrug
359,359,uridine triacetate,NDA,2015,uridine triacetate,DB09144,approved; investigational,CC(=O)OC[C@H]1O[C@H]([C@H](OC(C)=O)[C@@H]1OC(C)=O)N1C=CC(=O)NC1=O,Uridine triacetate,SmallMoleculeDrug
360,360,cariprazine,NDA,2015,cariprazine,DB06016,approved; investigational,CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)C2=C(Cl)C(Cl)=CC=C2)CC1,Cariprazine,SmallMoleculeDrug
361,361,aripiprazole lauroxil,NDA,2015,aripiprazole lauroxil,DB14185,approved; investigational,CCCCCCCCCCCC(=O)OCN1C(=O)CCC2=CC=C(OCCCCN3CCN(CC3)C3=C(Cl)C(Cl)=CC=C3)C=C12,Aripiprazole lauroxil,SmallMoleculeDrug
362,362,trabectedin,NDA,2015,trabectedin,DB05109,approved; investigational,[H][C@@]12[C@@H]3SC[C@]4(NCCC5=C4C=C(OC)C(O)=C5)C(=O)OC[C@H](N1[C@@H](O)[C@@H]1CC4=CC(C)=C(OC)C(O)=C4[C@H]2N1C)C1=C2OCOC2=C(C)C(OC(C)=O)=C31,Trabectedin,SmallMoleculeDrug
363,363,cobimetinib,NDA,2015,cobimetinib,DB05239,approved; investigational,OC1(CN(C1)C(=O)C1=C(NC2=C(F)C=C(I)C=C2)C(F)=C(F)C=C1)[C@@H]1CCCCN1,Cobimetinib,SmallMoleculeDrug
364,364,osimertinib,NDA,2015,osimertinib,DB09330,approved,COC1=C(NC2=NC=CC(=N2)C2=CN(C)C3=C2C=CC=C3)C=C(NC(=O)C=C)C(=C1)N(C)CCN(C)C,Osimertinib,SmallMoleculeDrug
365,365,ixazomib,NDA,2015,ixazomib,DB09570,approved; investigational,CC(C)C[C@H](NC(=O)CNC(=O)C1=CC(Cl)=CC=C1Cl)B(O)O,Ixazomib,SmallMoleculeDrug
366,366,alectinib,NDA,2015,alectinib,DB11363,approved; investigational,CCC1=CC2=C(C=C1N1CCC(CC1)N1CCOCC1)C(C)(C)C1=C(C3=CC=C(C=C3N1)C#N)C2=O,Alectinib,SmallMoleculeDrug
367,367,sugammadex,NDA,2015,sugammadex,DB06206,approved,O[C@@H]1[C@@H](O)[C@@H]2O[C@H]3O[C@H](CSCCC(O)=O)[C@@H](O[C@H]4O[C@H](CSCCC(O)=O)[C@@H](O[C@H]5O[C@H](CSCCC(O)=O)[C@@H](O[C@H]6O[C@H](CSCCC(O)=O)[C@@H](O[C@H]7O[C@H](CSCCC(O)=O)[C@@H](O[C@H]8O[C@H](CSCCC(O)=O)[C@@H](O[C@H]9O[C@H](CSCCC(O)=O)[C@@H](O[C@H]1O[C@@H]2CSCCC(O)=O)[C@H](O)[C@H]9O)[C@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O,Sugammadex,SmallMoleculeDrug
368,368,selexipag,NDA,2015,selexipag,DB11362,approved,CC(C)N(CCCCOCC(=O)NS(C)(=O)=O)C1=NC(C2=CC=CC=C2)=C(N=C1)C1=CC=CC=C1,Selexipag,SmallMoleculeDrug
369,369,lesinurad,NDA,2015,lesinurad,DB11560,approved; investigational,OC(=O)CSC1=NN=C(Br)N1C1=CC=C(C2CC2)C2=C1C=CC=C2,Lesinurad,SmallMoleculeDrug
370,370,brivaracetam,NDA,2016,brivaracetam,DB05541,approved; investigational,CCC[C@H]1CN([C@@H](CC)C(N)=O)C(=O)C1,Brivaracetam,SmallMoleculeDrug
371,371,venetoclax,NDA,2016,venetoclax,DB11581,approved; investigational,CC1(C)CCC(CN2CCN(CC2)C2=CC=C(C(=O)NS(=O)(=O)C3=CC=C(NCC4CCOCC4)C(=C3)[N+]([O-])=O)C(OC3=CN=C4NC=CC4=C3)=C2)=C(C1)C1=CC=C(Cl)C=C1,Venetoclax,SmallMoleculeDrug
372,372,pimavanserin,NDA,2016,pimavanserin,DB05316,approved; investigational,CC(C)COC1=CC=C(CNC(=O)N(CC2=CC=C(F)C=C2)C2CCN(C)CC2)C=C1,Pimavanserin,SmallMoleculeDrug
373,373,obeticholic acid,NDA,2016,obeticholic acid,DB05990,approved,[H][C@@]1(CC[C@@]2([H])[C@]3([H])[C@H](O)[C@H](CC)[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CCC(O)=O,Obeticholic acid,SmallMoleculeDrug
374,374,lifitegrast,NDA,2016,lifitegrast,DB11611,approved,CS(=O)(=O)C1=CC(C[C@H](NC(=O)C2=C(Cl)C3=C(CN(CC3)C(=O)C3=CC=C4C=COC4=C3)C=C2Cl)C(O)=O)=CC=C1,Lifitegrast,SmallMoleculeDrug
375,375,crisaborole,NDA,2016,crisaborole,DB05219,approved; investigational,OB1OCC2=C1C=CC(OC1=CC=C(C=C1)C#N)=C2,Crisaborole,SmallMoleculeDrug
376,376,rucaparib,NDA,2016,rucaparib,DB12332,approved; investigational,CNCC1=CC=C(C=C1)C1=C2CCNC(=O)C3=C2C(N1)=CC(F)=C3,Rucaparib,SmallMoleculeDrug
377,377,plecanatide,NDA,2017,plecanatide,DB13170,approved; investigational,[H][C@@]12CSSC[C@H](NC(=O)CNC(=O)[C@@]([H])(NC(=O)[C@]([H])(CSSC[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N1)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC2=O)C(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O,Plecanatide,SmallMoleculeDrug
378,378,etelcalcetide,NDA,2017,etelcalcetide,DB12865,approved; investigational,C[C@@H](NC(=O)[C@@H](CCCNC(N)=N)NC(=O)[C@@H](CCCNC(N)=N)NC(=O)[C@@H](CCCNC(N)=N)NC(=O)[C@@H](C)NC(=O)[C@@H](CSSC[C@H](N)C(O)=O)NC(C)=O)C(=O)N[C@H](CCCNC(N)=N)C(N)=O,Etelcalcetide,SmallMoleculeDrug
379,379,deflazacort,NDA,2017,deflazacort,DB11921,approved; investigational,[H][C@@]12C[C@@]3([H])[C@]4([H])CCC5=CC(=O)C=C[C@]5(C)[C@@]4([H])[C@@]([H])(O)C[C@]3(C)[C@@]1(N=C(C)O2)C(=O)COC(C)=O,Deflazacort,SmallMoleculeDrug
380,380,telotristat ethyl,NDA,2017,telotristat ethyl,DB12095,approved; investigational,CCOC(=O)[C@@H](N)CC1=CC=C(C=C1)C1=NC(N)=NC(O[C@H](C2=CC=C(Cl)C=C2N2C=CC(C)=N2)C(F)(F)F)=C1,Telotristat ethyl,SmallMoleculeDrug
381,381,ribociclib,NDA,2017,ribociclib,DB11730,approved; investigational,CN(C)C(=O)C1=CC2=CN=C(NC3=CC=C(C=N3)N3CCNCC3)N=C2N1C1CCCC1,Ribociclib,SmallMoleculeDrug
382,382,safinamide,NDA,2017,safinamide,DB06654,approved; investigational,C[C@H](NCC1=CC=C(OCC2=CC(F)=CC=C2)C=C1)C(N)=O,Safinamide,SmallMoleculeDrug
383,383,naldemedine,NDA,2017,naldemedine,DB11691,approved; investigational,[H][C@@]12OC3=C4C(C[C@@]5([H])N(CC6CC6)CC[C@@]14[C@@]5(O)CC(C(=O)NC(C)(C)C1=NC(=NO1)C1=CC=CC=C1)=C2O)=CC=C3O,Naldemedine,SmallMoleculeDrug
384,384,niraparib,NDA,2017,niraparib,DB11793,approved; investigational,NC(=O)C1=CC=CC2=CN(N=C12)C1=CC=C(C=C1)[C@@H]1CCCNC1,Niraparib,SmallMoleculeDrug
385,385,deutetrabenazine,NDA,2017,deutetrabenazine,DB12161,approved; investigational,[2H]C([2H])([2H])OC1=CC2=C(C=C1OC([2H])([2H])[2H])[C@@H]1CC(=O)[C@@H](CC(C)C)CN1CC2,Deutetrabenazine,SmallMoleculeDrug
386,386,valbenazine,NDA,2017,valbenazine,DB11915,approved; investigational,COC1=C(OC)C=C2[C@H]3C[C@@H](OC(=O)[C@@H](N)C(C)C)[C@H](CC(C)C)CN3CCC2=C1,Valbenazine,SmallMoleculeDrug
387,387,midostaurin,NDA,2017,midostaurin,DB06595,approved; investigational,CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O)N(C)C(=O)C1=CC=CC=C1,Midostaurin,SmallMoleculeDrug
388,388,brigatinib,NDA,2017,brigatinib,DB12267,approved; investigational,COC1=CC(=CC=C1NC1=NC=C(Cl)C(NC2=CC=CC=C2P(C)(C)=O)=N1)N1CCC(CC1)N1CCN(C)CC1,Brigatinib,SmallMoleculeDrug
389,389,edaravone,NDA,2017,edaravone,DB12243,approved; investigational,CC1=NN(C(=O)C1)C1=CC=CC=C1,Edaravone,SmallMoleculeDrug
390,390,delafloxacin,NDA,2017,delafloxacin,DB11943,approved; investigational,NC1=NC(N2C=C(C(O)=O)C(=O)C3=CC(F)=C(N4CC(O)C4)C(Cl)=C23)=C(F)C=C1F,Delafloxacin,SmallMoleculeDrug
391,391,betrixaban,NDA,2017,betrixaban,DB12364,approved; investigational,COC1=CC=C(NC(=O)C2=CC=C(C=C2)C(=N)N(C)C)C(=C1)C(=O)NC1=CC=C(Cl)C=N1,Betrixaban,SmallMoleculeDrug
392,392,neratinib,NDA,2017,neratinib,DB11828,approved; investigational,CCOC1=C(NC(=O)\C=C\CN(C)C)C=C2C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C(C=NC2=C1)C#N,Neratinib,SmallMoleculeDrug
393,393,enasidenib,NDA,2017,enasidenib,DB13874,approved; investigational,CC(C)(O)CNC1=NC(=NC(NC2=CC(=NC=C2)C(F)(F)F)=N1)C1=NC(=CC=C1)C(F)(F)F,Enasidenib,SmallMoleculeDrug
394,394,benznidazole,NDA,2017,benznidazole,DB11989,approved; investigational,[O-][N+](=O)C1=NC=CN1CC(=O)NCC1=CC=CC=C1,Benznidazole,SmallMoleculeDrug
395,395,copanlisib,NDA,2017,copanlisib,DB12483,approved; investigational,COC1=C(OCCCN2CCOCC2)C=CC2=C1N=C(NC(=O)C1=CN=C(N)N=C1)N1CCN=C21,Copanlisib,SmallMoleculeDrug
396,396,secnidazole,NDA,2017,secnidazole,DB12834,approved,CC(O)CN1C(C)=NC=C1N(=O)=O,Secnidazole,SmallMoleculeDrug
397,397,abemaciclib,NDA,2017,abemaciclib,DB12001,approved; investigational,CCN1CCN(CC2=CC=C(NC3=NC=C(F)C(=N3)C3=CC(F)=C4N=C(C)N(C(C)C)C4=C3)N=C2)CC1,Abemaciclib,SmallMoleculeDrug
398,398,acalabrutinib,NDA,2017,acalabrutinib,DB11703,approved; investigational,CC#CC(=O)N1CCC[C@H]1C1=NC(=C2N1C=CN=C2N)C1=CC=C(C=C1)C(=O)NC1=CC=CC=N1,Acalabrutinib,SmallMoleculeDrug
399,399,latanoprostene bunod,NDA,2017,latanoprostene bunod,DB11660,approved; investigational,O[C@H](CC[C@H]1[C@H](O)C[C@H](O)[C@@H]1C\C=C/CCCC(=O)OCCCCO[N+]([O-])=O)CCC1=CC=CC=C1,Latanoprostene bunod,SmallMoleculeDrug
400,400,letermovir,NDA,2017,letermovir,DB12070,approved; investigational,COC1=CC=CC(=C1)N1CCN(CC1)C1=NC2=C(C=CC=C2F)[C@H](CC(O)=O)N1C1=CC(=CC=C1OC)C(F)(F)F,Letermovir,SmallMoleculeDrug
401,401,semaglutide,NDA,2017,semaglutide,DB13928,approved; investigational,CC[C@H](C)[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCNC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CC[C@@H](NC(=O)CCCCCCCCCCCCCCCCC(O)=O)C(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)C(C)(C)NC(=O)[C@@H](N)CC1=CN=CN1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O,Semaglutide,SmallMoleculeDrug
402,402,ozenoxacin,NDA,2017,ozenoxacin,DB12924,approved; investigational,CNC1=NC=C(C=C1C)C1=CC=C2C(=O)C(=CN(C3CC3)C2=C1C)C(O)=O,Ozenoxacin,SmallMoleculeDrug
403,403,netarsudil,NDA,2017,netarsudil,DB13931,approved,CC1=CC(C)=C(C=C1)C(=O)OCC1=CC=C(C=C1)[C@@H](CN)C(=O)NC1=CC=C2C=NC=CC2=C1,Netarsudil,SmallMoleculeDrug
404,404,ertugliflozin,NDA,2017,ertugliflozin,DB11827,approved; investigational,CCOC1=CC=C(CC2=CC(=CC=C2Cl)[C@]23OC[C@](CO)(O2)[C@@H](O)[C@H](O)[C@H]3O)C=C1,Ertugliflozin,SmallMoleculeDrug
405,405,macimorelin,NDA,2017,macimorelin,DB13074,approved; investigational,CC(C)(N)C(=O)N[C@H](CC1=CNC2=CC=CC=C12)C(=O)N[C@H](CC1=CNC2=CC=CC=C12)NC=O,Macimorelin,SmallMoleculeDrug
406,406,apalutamide,NDA,2018,apalutamide,DB11901,approved; investigational,CNC(=O)C1=CC=C(C=C1F)N1C(=S)N(C(=O)C11CCC1)C1=CC(=C(N=C1)C#N)C(F)(F)F,Apalutamide,SmallMoleculeDrug
407,407,fostamatinib disodium hexahydrate,NDA,2018,fostamatinib,DB12010,approved; investigational,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC,Fostamatinib,SmallMoleculeDrug
408,408,lofexidine,NDA,2018,lofexidine,DB04948,approved; investigational,CC(OC1=C(Cl)C=CC=C1Cl)C1=NCCN1,Lofexidine,SmallMoleculeDrug
409,409,avatrombopag,NDA,2018,avatrombopag,DB11995,approved; investigational,OC(=O)C1CCN(CC1)C1=C(Cl)C=C(C=N1)C(=O)NC1=NC(C2=CC(Cl)=CS2)=C(S1)N1CCN(CC1)C1CCCCC1,Avatrombopag,SmallMoleculeDrug
410,410,baricitinib,NDA,2018,baricitinib,DB11817,approved; investigational,CCS(=O)(=O)N1CC(CC#N)(C1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1,Baricitinib,SmallMoleculeDrug
411,411,moxidectin,NDA,2018,moxidectin,DB11431,approved; investigational; vet_approved,[H][C@@]12OC\C3=C/C=C/[C@H](C)C\C(C)=C\C[C@]4([H])C[C@@]([H])(C[C@]5(C\C(=N/OC)[C@H](C)[C@H](O5)C(\C)=C\C(C)C)O4)OC(=O)[C@]([H])(C=C(C)[C@H]1O)[C@@]23O,Moxidectin,SmallMoleculeDrug
412,412,plazomicin,NDA,2018,plazomicin,DB12615,approved; investigational,CN[C@@H]1[C@@H](O)[C@@H](O[C@H]2[C@@H](C[C@H](N)[C@@H](O[C@H]3OC(CNCCO)=CC[C@H]3N)[C@@H]2O)NC(=O)[C@@H](O)CCN)OC[C@]1(C)O,Plazomicin,SmallMoleculeDrug
413,413,cannabidiol,NDA,2018,cannabidiol,DB09061,approved; investigational,CCCCCC1=CC(O)=C([C@@H]2C=C(C)CC[C@H]2C(C)=C)C(O)=C1,Cannabidiol,SmallMoleculeDrug
414,414,encorafenib,NDA,2018,encorafenib,DB11718,approved; investigational,COC(=O)N[C@@H](C)CNC1=NC=CC(=N1)C1=CN(N=C1C1=CC(Cl)=CC(NS(C)(=O)=O)=C1F)C(C)C,Encorafenib,SmallMoleculeDrug
415,415,binimetinib,NDA,2018,binimetinib,DB11967,approved; investigational,CN1C=NC2=C(F)C(NC3=CC=C(Br)C=C3F)=C(C=C12)C(=O)NOCCO,Binimetinib,SmallMoleculeDrug
416,416,tecovirimat,NDA,2018,tecovirimat,DB12020,approved; investigational,FC(F)(F)C1=CC=C(C=C1)C(=O)NN1C(=O)[C@H]2[C@H]([C@H]3C=C[C@@H]2[C@@H]2C[C@H]32)C1=O,Tecovirimat,SmallMoleculeDrug
417,417,tafenoquine,NDA,2018,tafenoquine,DB06608,approved; investigational,COC1=CC(C)=C2C(OC3=CC=CC(=C3)C(F)(F)F)=C(OC)C=C(NC(C)CCCN)C2=N1,Tafenoquine,SmallMoleculeDrug
418,418,ivosidenib,NDA,2018,ivosidenib,DB14568,approved; investigational,[H][C@@](N(C(=O)[C@]1([H])CCC(=O)N1C1=NC=CC(=C1)C#N)C1=CC(F)=CN=C1)(C(=O)NC1CC(F)(F)C1)C1=C(Cl)C=CC=C1,Ivosidenib,SmallMoleculeDrug
419,419,elagolix,NDA,2018,elagolix,DB11979,approved; investigational,COC1=CC=CC(=C1F)C1=C(C)N(CC2=C(C=CC=C2F)C(F)(F)F)C(=O)N(C[C@H](NCCCC(O)=O)C2=CC=CC=C2)C1=O,Elagolix,SmallMoleculeDrug
420,420,lusutrombopag,NDA,2018,lusutrombopag,DB13125,approved; investigational,CCCCCCO[C@@H](C)C1=C(OC)C(=CC=C1)C1=CSC(NC(=O)C2=CC(Cl)=C(\C=C(/C)C(O)=O)C(Cl)=C2)=N1,Lusutrombopag,SmallMoleculeDrug
421,421,migalastat,NDA,2018,migalastat,DB05018,approved; investigational,OC[C@H]1NC[C@H](O)[C@@H](O)[C@H]1O,Migalastat,SmallMoleculeDrug
422,422,stiripentol,NDA,2018,stiripentol,DB09118,approved,CC(C)(C)C(O)\C=C\C1=CC2=C(OCO2)C=C1,Stiripentol,SmallMoleculeDrug
423,423,eravacycline,NDA,2018,eravacycline,DB12329,approved; investigational,[H][C@@]12CC3=C(F)C=C(NC(=O)CN4CCCC4)C(O)=C3C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])C2,Eravacycline,SmallMoleculeDrug
424,424,doravirine,NDA,2018,doravirine,DB12301,approved; investigational,CN1C(=O)NN=C1CN1C=CC(=C(OC2=CC(=CC(Cl)=C2)C#N)C1=O)C(F)(F)F,Doravirine,SmallMoleculeDrug
425,425,duvelisib,NDA,2018,duvelisib,DB11952,approved; investigational,C[C@H](NC1=C2N=CNC2=NC=N1)C1=CC2=CC=CC(Cl)=C2C(=O)N1C1=CC=CC=C1,Duvelisib,SmallMoleculeDrug
426,426,dacomitinib,NDA,2018,dacomitinib,DB11963,approved; investigational,COC1=C(NC(=O)\C=C\CN2CCCCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1,Dacomitinib,SmallMoleculeDrug
427,427,sarecycline,NDA,2018,sarecycline,DB12035,approved; investigational,[H][C@@]12CC3=C(CN(C)OC)C=CC(O)=C3C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])C2,Sarecycline,SmallMoleculeDrug
428,428,omadacycline,NDA,2018,omadacycline,DB12455,approved; investigational,[H][C@@]12CC3=C(C=C(CNCC(C)(C)C)C(O)=C3C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])C2)N(C)C,Omadacycline,SmallMoleculeDrug
429,429,talazoparib,NDA,2018,talazoparib,DB11760,approved; investigational,CN1N=CN=C1[C@@H]1[C@H](NC2=C3C1=NNC(=O)C3=CC(F)=C2)C1=CC=C(F)C=C1,Talazoparib,SmallMoleculeDrug
430,430,baloxavir marboxil,NDA,2018,baloxavir marboxil,DB13997,approved; investigational,[H][C@@]12COCCN1C(=O)C1=C(OCOC(=O)OC)C(=O)C=CN1N2[C@H]1C2=CC=C(F)C(F)=C2CSC2=CC=CC=C12,Baloxavir marboxil,SmallMoleculeDrug
431,431,lorlatinib,NDA,2018,lorlatinib,DB12130,approved; investigational,C[C@H]1OC2=C(N)N=CC(=C2)C2=C(C#N)N(C)N=C2CN(C)C(=O)C2=C1C=C(F)C=C2,Lorlatinib,SmallMoleculeDrug
432,432,revefenacin,NDA,2018,revefenacin,DB11855,approved; investigational,CN(CCN1CCC(CC1)OC(=O)NC1=CC=CC=C1C1=CC=CC=C1)C(=O)C1=CC=C(CN2CCC(CC2)C(N)=O)C=C1,Revefenacin,SmallMoleculeDrug
433,433,rifamycin,NDA,2018,rifamycin,DB11753,approved; investigational,CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C)C(O)=C4C(O)=C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C=C(O)C4=C3C2=O,Rifamycin,SmallMoleculeDrug
434,434,glasdegib,NDA,2018,glasdegib,DB11978,approved; investigational,CN1CC[C@H](C[C@@H]1C1=NC2=CC=CC=C2N1)NC(=O)NC1=CC=C(C=C1)C#N,Glasdegib,SmallMoleculeDrug
435,435,larotrectinib,NDA,2018,larotrectinib,DB14723,approved; investigational,O[C@H]1CCN(C1)C(=O)NC1=C2N=C(C=CN2N=C1)N1CCC[C@@H]1C1=C(F)C=CC(F)=C1,Larotrectinib,SmallMoleculeDrug
436,436,amifampridine,NDA,2018,amifampridine,DB11640,approved; investigational,NC1=CC=NC=C1N,Amifampridine,SmallMoleculeDrug
437,437,gilteritinib,NDA,2018,gilteritinib,DB12141,approved; investigational,CCC1=C(NC2CCOCC2)N=C(NC2=CC=C(N3CCC(CC3)N3CCN(C)CC3)C(OC)=C2)C(=N1)C(N)=O,Gilteritinib,SmallMoleculeDrug
438,438,prucalopride,NDA,2018,prucalopride,DB06480,approved,COCCCN1CCC(CC1)NC(=O)C1=C2OCCC2=C(N)C(Cl)=C1,Prucalopride,SmallMoleculeDrug
439,439,triclabendazole,NDA,2019,triclabendazole,DB12245,approved; investigational,CSC1=NC2=C(N1)C=C(Cl)C(OC1=CC=CC(Cl)=C1Cl)=C2,Triclabendazole,SmallMoleculeDrug
440,440,brexanolone,NDA,2019,brexanolone,DB11859,approved; investigational,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC[C@@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)C(C)=O,Brexanolone,SmallMoleculeDrug
441,441,solriamfetol,NDA,2019,solriamfetol,DB14754,approved,N[C@@H](COC(N)=O)CC1=CC=CC=C1,Solriamfetol,SmallMoleculeDrug
442,442,siponimod,NDA,2019,siponimod,DB12371,approved; investigational,CCC1=CC(=CC=C1CN1CC(C1)C(O)=O)C(\C)=N\OCC1=CC=C(C2CCCCC2)C(=C1)C(F)(F)F,Siponimod,SmallMoleculeDrug
443,443,erdafitinib,NDA,2019,erdafitinib,DB12147,approved; investigational,COC1=CC(=CC(OC)=C1)N(CCNC(C)C)C1=CC=C2N=CC(=NC2=C1)C1=CN(C)N=C1,Erdafitinib,SmallMoleculeDrug
444,444,alpelisib,NDA,2019,alpelisib,DB12015,approved; investigational,CC1=C(SC(NC(=O)N2CCC[C@H]2C(N)=O)=N1)C1=CC(=NC=C1)C(C)(C)C(F)(F)F,Alpelisib,SmallMoleculeDrug
445,445,bremelanotide,NDA,2019,bremelanotide,DB11653,approved; investigational,CCCC[C@H](NC(C)=O)C(=O)N[C@H]1CC(=O)NCCCC[C@H](NC(=O)[C@H](CC2=CNC3=CC=CC=C23)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CN=CN2)NC1=O)C(O)=O,Bremelanotide,SmallMoleculeDrug
446,446,selinexor,NDA,2019,selinexor,DB11942,approved; investigational,FC(F)(F)C1=CC(=CC(=C1)C1=NN(\C=C/C(=O)NNC2=NC=CN=C2)C=N1)C(F)(F)F,Selinexor,SmallMoleculeDrug
447,447,ferric maltol,NDA,2019,ferric maltol,DB15598,approved,[Fe+3].CC1=C([O-])C(=O)C=CO1.CC1=C([O-])C(=O)C=CO1.CC1=C([O-])C(=O)C=CO1,Ferric maltol,SmallMoleculeDrug
448,448,darolutamide,NDA,2019,darolutamide,DB12941,approved; investigational,C[C@@H](CN1C=CC(=N1)C1=CC=C(C#N)C(Cl)=C1)NC(=O)C1=NNC(=C1)C(C)O,Darolutamide,SmallMoleculeDrug
449,449,pexidartinib,NDA,2019,pexidartinib,DB12978,approved; investigational,FC(F)(F)C1=CC=C(CNC2=NC=C(CC3=CNC4=NC=C(Cl)C=C34)C=C2)C=N1,Pexidartinib,SmallMoleculeDrug
450,450,pitolisant,NDA,2019,pitolisant,DB11642,approved; investigational,ClC1=CC=C(CCCOCCCN2CCCCC2)C=C1,Pitolisant,SmallMoleculeDrug
451,451,pretomanid,NDA,2019,pretomanid,DB05154,approved,[O-][N+](=O)C1=CN2C[C@@H](COC2=N1)OCC1=CC=C(OC(F)(F)F)C=C1,Pretomanid,SmallMoleculeDrug
452,452,entrectinib,NDA,2019,entrectinib,DB11986,approved; investigational,CN1CCN(CC1)C1=CC=C(C(=O)NC2=NNC3=CC=C(CC4=CC(F)=CC(F)=C4)C=C23)C(NC2CCOCC2)=C1,Entrectinib,SmallMoleculeDrug
453,453,fedratinib,NDA,2019,fedratinib,DB12500,approved; investigational,CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C,Fedratinib,SmallMoleculeDrug
454,454,upadacitinib,NDA,2019,upadacitinib,DB15091,approved; investigational,CC[C@@H]1CN(C[C@@H]1C1=CN=C2C=NC3=C(C=CN3)N12)C(=O)NCC(F)(F)F,Upadacitinib,SmallMoleculeDrug
455,455,lefamulin,NDA,2019,lefamulin,DB12825,approved; investigational,[H][C@@]12C(=O)CC[C@]11CCC(C)[C@@]2(C)[C@@H](C[C@@](C)(C=C)[C@@H](O)[C@@H]1C)OC(=O)CS[C@@H]1CC[C@@H](N)C[C@H]1O,Lefamulin,SmallMoleculeDrug
456,456,istradefylline,NDA,2019,istradefylline,DB11757,approved; investigational,[H]\C(=C(\[H])C1=CC(OC)=C(OC)C=C1)C1=NC2=C(N1C)C(=O)N(CC)C(=O)N2CC,Istradefylline,SmallMoleculeDrug
457,457,tenapanor,NDA,2019,tenapanor,DB11761,approved; investigational,CN1C[C@@H](C2=CC(=CC=C2)S(=O)(=O)NCCOCCOCCNC(=O)NCCCCNC(=O)NCCOCCOCCNS(=O)(=O)C2=CC(=CC=C2)[C@@H]2CN(C)CC3=C2C=C(Cl)C=C3Cl)C2=C(C1)C(Cl)=CC(Cl)=C2,Tenapanor,SmallMoleculeDrug
458,458,trifarotene,NDA,2019,trifarotene,DB12808,approved; investigational,CC(C)(C)C1=CC(=CC=C1N1CCCC1)C1=CC(=CC=C1OCCO)C1=CC=C(C=C1)C(O)=O,Trifarotene,SmallMoleculeDrug
459,459,afamelanotide,NDA,2019,afamelanotide,DB04931,approved; investigational,CCCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(C)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CNC2=CC=CC=C12)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(N)=O,Afamelanotide,SmallMoleculeDrug
460,460,lasmiditan,NDA,2019,lasmiditan,DB11732,approved; investigational,CN1CCC(CC1)C(=O)C1=CC=CC(NC(=O)C2=C(F)C=C(F)C=C2F)=N1,Lasmiditan,SmallMoleculeDrug
461,461,zanubrutinib,NDA,2019,zanubrutinib,DB15035,approved; investigational,NC(=O)C1=C2NCC[C@@H](C3CCN(CC3)C(=O)C=C)N2N=C1C1=CC=C(OC2=CC=CC=C2)C=C1,Zanubrutinib,SmallMoleculeDrug
462,462,cefiderocol,NDA,2019,cefiderocol,DB14879,approved; investigational,[H][C@]12SCC(C[N+]3(CCNC(=O)C4=C(Cl)C(O)=C(O)C=C4)CCCC3)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC(C)(C)C(O)=O)\C1=CSC(N)=N1)C([O-])=O,Cefiderocol,SmallMoleculeDrug
463,463,cenobamate,NDA,2019,cenobamate,DB06119,approved; investigational,NC(=O)O[C@@H](CN1N=CN=N1)C1=C(Cl)C=CC=C1,Cenobamate,SmallMoleculeDrug
464,464,voxelotor,NDA,2019,voxelotor,DB14975,approved; investigational,CC(C)N1N=CC=C1C1=C(COC2=CC=CC(O)=C2C=O)C=CC=N1,Voxelotor,SmallMoleculeDrug
465,465,lumateperone,NDA,2019,lumateperone,DB06077,approved; investigational,[H][C@]12CCN(CCCC(=O)C3=CC=C(F)C=C3)C[C@@]1([H])C1=CC=CC3=C1N2CCN3C,Lumateperone,SmallMoleculeDrug
466,466,lemborexant,NDA,2019,lemborexant,DB11951,approved; investigational,CC1=NC=C(OC[C@]2(C[C@H]2C(=O)NC2=NC=C(F)C=C2)C2=CC=CC(F)=C2)C(C)=N1,Lemborexant,SmallMoleculeDrug
467,467,ubrogepant,NDA,2019,ubrogepant,DB15328,approved; investigational,C[C@@H]1[C@@H](C[C@H](NC(=O)C2=CN=C3C[C@]4(CC3=C2)C(=O)NC2=NC=CC=C42)C(=O)N1CC(F)(F)F)C1=CC=CC=C1,Ubrogepant,SmallMoleculeDrug
468,468,avapritinib,NDA,2020,avapritinib,DB15233,approved; investigational,CN1C=C(C=N1)C1=CN2N=CN=C(N3CCN(CC3)C3=NC=C(C=N3)[C@@](C)(N)C3=CC=C(F)C=C3)C2=C1,Avapritinib,SmallMoleculeDrug
469,469,tazemetostat,NDA,2020,tazemetostat,DB12887,approved; investigational,CCN(C1CCOCC1)C1=C(C)C(=CC(=C1)C1=CC=C(CN2CCOCC2)C=C1)C(=O)NCC1=C(C)C=C(C)NC1=O,Tazemetostat,SmallMoleculeDrug
470,470,lactitol,NDA,2020,lactitol,DB12942,approved; investigational,OC[C@H](O)[C@@H](O)[C@H](O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)[C@H](O)CO,Lactitol,SmallMoleculeDrug
471,471,bempedoic acid,NDA,2020,bempedoic acid,DB11936,approved; investigational,CC(C)(CCCCCC(O)CCCCCC(C)(C)C(O)=O)C(O)=O,Bempedoic acid,SmallMoleculeDrug
472,472,amisulpride,NDA,2020,amisulpride,DB06288,approved; investigational,CCN1CCCC1CNC(=O)C1=CC(=C(N)C=C1OC)S(=O)(=O)CC,Amisulpride,SmallMoleculeDrug
473,473,rimegepant,NDA,2020,rimegepant,DB12457,approved; investigational,N[C@H]1[C@@H](CC[C@@H](OC(=O)N2CCC(CC2)N2C(=O)NC3=NC=CC=C23)C2=C1C=CC=N2)C1=C(F)C(F)=CC=C1,Rimegepant,SmallMoleculeDrug
474,474,osilodrostat,NDA,2020,osilodrostat,DB11837,approved; investigational,FC1=C(C=CC(=C1)C#N)[C@H]1CCC2=CN=CN12,Osilodrostat,SmallMoleculeDrug
475,475,ozanimod,NDA,2020,ozanimod,DB12612,approved; investigational,CC(C)OC1=C(C=C(C=C1)C1=NC(=NO1)C1=C2CC[C@H](NCCO)C2=CC=C1)C#N,Ozanimod,SmallMoleculeDrug
476,476,selumetinib,NDA,2020,selumetinib,DB11689,approved; investigational,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO,Selumetinib,SmallMoleculeDrug
477,477,pemigatinib,NDA,2020,pemigatinib,DB15102,approved; investigational,CCN1C(=O)N(CC2=CN=C3NC(CN4CCOCC4)=CC3=C12)C1=C(F)C(OC)=CC(OC)=C1F,Pemigatinib,SmallMoleculeDrug
478,478,tucatinib,NDA,2020,tucatinib,DB11652,approved; investigational,CC1=CC(NC2=NC=NC3=CC=C(NC4=NC(C)(C)CO4)C=C23)=CC=C1OC1=CC2=NC=NN2C=C1,Tucatinib,SmallMoleculeDrug
479,479,opicapone,NDA,2020,opicapone,DB11632,approved; investigational,CC1=C(C2=NOC(=N2)C2=CC(=C(O)C(O)=C2)[N+]([O-])=O)C(Cl)=[N+]([O-])C(C)=C1Cl,Opicapone,SmallMoleculeDrug
480,480,capmatinib,NDA,2020,capmatinib,DB11791,approved; investigational,CNC(=O)C1=C(F)C=C(C=C1)C1=NN2C(CC3=CC4=C(C=C3)N=CC=C4)=CN=C2N=C1,Capmatinib,SmallMoleculeDrug
481,481,selpercatinib,NDA,2020,selpercatinib,DB15685,approved; investigational,COC1=NC=C(CN2C3CC2CN(C3)C2=CC=C(C=N2)C2=CC(OCC(C)(C)O)=CN3N=CC(C#N)=C23)C=C1,Selpercatinib,SmallMoleculeDrug
482,482,ripretinib,NDA,2020,ripretinib,DB14840,approved,CCN1C(=O)C(=CC2=C1C=C(NC)N=C2)C1=C(Br)C=C(F)C(NC(=O)NC2=CC=CC=C2)=C1,Ripretinib,SmallMoleculeDrug
483,483,artesunate,NDA,2020,artesunate,DB09274,approved; investigational,[H][C@@]12CC[C@@H](C)[C@]3([H])CC[C@@]4(C)OO[C@@]13[C@]([H])(O[C@@H](OC(=O)CCC(O)=O)[C@@H]2C)O4,Artesunate,SmallMoleculeDrug
484,484,lurbinectedin,NDA,2020,lurbinectedin,DB12674,approved; investigational,[H][C@@]12[C@@H]3SC[C@]4(NCCC5=C4NC4=CC=C(OC)C=C54)C(=O)OC[C@H](N1[C@@H](O)[C@@H]1CC4=CC(C)=C(OC)C(O)=C4[C@@]2([H])N1C)C1=C2OCOC2=C(C)C(OC(C)=O)=C31,Lurbinectedin,SmallMoleculeDrug
485,485,triheptanoin,NDA,2020,triheptanoin,DB11677,approved; investigational,CCCCCCC(=O)OCC(COC(=O)CCCCCC)OC(=O)CCCCCC,Triheptanoin,SmallMoleculeDrug
486,486,remimazolam,NDA,2020,remimazolam,DB12404,approved; investigational,COC(=O)CC[C@@H]1N=C(C2=CC=CC=N2)C2=CC(Br)=CC=C2N2C(C)=CN=C12,Remimazolam,SmallMoleculeDrug
487,487,fostemsavir,NDA,2020,fostemsavir,DB11796,approved; investigational,COC1=CN=C(N2C=NC(C)=N2)C2=C1C(=CN2COP(O)(O)=O)C(=O)C(=O)N1CCN(CC1)C(=O)C1=CC=CC=C1,Fostemsavir,SmallMoleculeDrug
488,488,abametapir,NDA,2020,abametapir,DB11932,approved; investigational,CC1=CC=C(N=C1)C1=CC=C(C)C=N1,Abametapir,SmallMoleculeDrug
489,489,nifurtimox,NDA,2020,nifurtimox,DB11820,approved; investigational,CC1CS(=O)(=O)CCN1\N=C\C1=CC=C(O1)[N+]([O-])=O,Nifurtimox,SmallMoleculeDrug
490,490,risdiplam,NDA,2020,risdiplam,DB15305,approved; investigational,CC1=CN2N=C(C=C(C)C2=N1)C1=CC(=O)N2C=C(C=CC2=N1)N1CCNC2(CC2)C1,Risdiplam,SmallMoleculeDrug
491,491,oliceridine,NDA,2020,oliceridine,DB14881,approved; investigational,COC1=C(CNCC[C@]2(CCOC3(CCCC3)C2)C2=NC=CC=C2)SC=C1,Oliceridine,SmallMoleculeDrug
492,492,clascoterone,NDA,2020,clascoterone,DB12499,approved; investigational,[H][C@@]12CC[C@](OC(=O)CC)(C(=O)CO)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,Clascoterone,SmallMoleculeDrug
493,493,pralsetinib,NDA,2020,pralsetinib,DB15822,approved; investigational,CO[C@]1(CC[C@@H](CC1)C1=NC(NC2=NNC(C)=C2)=CC(C)=N1)C(=O)N[C@@H](C)C1=CC=C(N=C1)N1C=C(F)C=N1,Pralsetinib,SmallMoleculeDrug
494,494,remdesivir,NDA,2020,remdesivir,DB14761,approved; investigational,CCC(CC)COC(=O)[C@H](C)N[P@](=O)(OC[C@H]1O[C@](C#N)([C@H](O)[C@@H]1O)C1=CC=C2N1N=CN=C2N)OC1=CC=CC=C1,Remdesivir,SmallMoleculeDrug
495,495,lonafarnib,NDA,2020,lonafarnib,DB06448,approved; investigational,NC(=O)N1CCC(CC(=O)N2CCC(CC2)[C@H]2C3=C(CCC4=C2C(Br)=CC(Cl)=C4)C=C(Br)C=N3)CC1,Lonafarnib,SmallMoleculeDrug
496,496,setmelanotide,NDA,2020,setmelanotide,DB11700,approved; investigational,[H]N([H])C(=O)[C@@H]1CSSC[C@H](N([H])C(=O)[C@H](CCCN=C(N([H])[H])N([H])[H])N([H])C(C)=O)C(=O)N[C@H](C)C(=O)N[C@@H](CC2=CN=CN2[H])C(=O)N[C@H](CC2=CC=CC=C2)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC2=CN([H])C3=CC=CC=C23)C(=O)N1,Setmelanotide,SmallMoleculeDrug
497,497,berotralstat,NDA,2020,berotralstat,DB15982,approved,NCC1=CC(=CC=C1)N1N=C(C=C1C(=O)NC1=CC(=CC=C1F)[C@H](NCC1CC1)C1=CC=CC(=C1)C#N)C(F)(F)F,Berotralstat,SmallMoleculeDrug
498,498,tirbanibulin,NDA,2020,tirbanibulin,DB06137,approved; investigational,O=C(CC1=CC=C(C=N1)C1=CC=C(OCCN2CCOCC2)C=C1)NCC1=CC=CC=C1,Tirbanibulin,SmallMoleculeDrug
499,499,relugolix,NDA,2020,relugolix,DB11853,approved; investigational,CONC(=O)NC1=CC=C(C=C1)C1=C(CN(C)C)C2=C(S1)N(CC1=C(F)C=CC=C1F)C(=O)N(C2=O)C1=CC=C(OC)N=N1,Relugolix,SmallMoleculeDrug
500,500,vibegron,NDA,2020,vibegron,DB14895,approved; investigational,[H][C@@]1(CC[C@@H](CC2=CC=C(NC(=O)[C@@H]3CCC4=NC=CC(=O)N34)C=C2)N1)[C@H](O)C1=CC=CC=C1,Vibegron,SmallMoleculeDrug
501,501,vericiguat,NDA,2021,vericiguat,DB15456,approved; investigational,COC(=O)NC1=C(N)N=C(N=C1N)C1=NN(CC2=CC=CC=C2F)C2=C1C=C(F)C=N2,Vericiguat,SmallMoleculeDrug
502,502,voclosporin,NDA,2021,voclosporin,DB11693,approved; investigational,[H][C@@]1([C@H](O)[C@H](C)C\C=C\C=C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C(=O)[C@H](CC)NC1=O)C(C)C,Voclosporin,SmallMoleculeDrug
503,503,tepotinib,NDA,2021,tepotinib,DB15133,approved; investigational,CN1CCC(COC2=CN=C(N=C2)C2=CC(CN3N=C(C=CC3=O)C3=CC(=CC=C3)C#N)=CC=C2)CC1,Tepotinib,SmallMoleculeDrug
504,504,umbralisib,NDA,2021,umbralisib,DB14989,approved; investigational,CC(C)OC1=C(F)C=C(C=C1)C1=NN([C@@H](C)C2=C(C3=CC=CC(F)=C3)C(=O)C3=CC(F)=CC=C3O2)C2=C1C(N)=NC=N2,Umbralisib,SmallMoleculeDrug
505,505,trilaciclib,NDA,2021,trilaciclib,DB15442,approved; investigational,CN1CCN(CC1)C1=CN=C(NC2=NC3=C(C=C4N3C3(CCCCC3)CNC4=O)C=N2)C=C1,Trilaciclib,SmallMoleculeDrug
506,506,fosdenopterin,NDA,2021,fosdenopterin,DB16628,approved,[H][C@@]12COP(O)(=O)O[C@]1([H])C(O)(O)[C@]1([H])NC3=C(NC(N)=NC3=O)N[C@]1([H])O2,Fosdenopterin,SmallMoleculeDrug
507,507,melphalan flufenamide,NDA,2021,melphalan flufenamide,DB16627,approved; withdrawn,CCOC(=O)[C@H](CC1=CC=C(F)C=C1)NC(=O)[C@@H](N)CC1=CC=C(C=C1)N(CCCl)CCCl,Melphalan flufenamide,SmallMoleculeDrug
508,508,tivozanib,NDA,2021,tivozanib,DB11800,approved; investigational,COC1=C(OC)C=C2C(OC3=CC(Cl)=C(NC(=O)NC4=NOC(C)=C4)C=C3)=CC=NC2=C1,Tivozanib,SmallMoleculeDrug
509,509,ponesimod,NDA,2021,ponesimod,DB12016,approved; investigational,CCC\N=C1/S\C(=C/C2=CC=C(OC[C@H](O)CO)C(Cl)=C2)C(=O)N1C1=CC=CC=C1C,Ponesimod,SmallMoleculeDrug
510,510,viloxazine,NDA,2021,viloxazine,DB09185,approved; investigational; withdrawn,CCOC1=CC=CC=C1OCC1CNCCO1,Viloxazine,SmallMoleculeDrug
511,511,sotorasib,NDA,2021,sotorasib,DB15569,approved; investigational,CC(C)C1=NC=CC(C)=C1N1C(=O)N=C(N2CCN(C[C@@H]2C)C(=O)C=C)C2=CC(F)=C(N=C12)C1=C(O)C=CC=C1F,Sotorasib,SmallMoleculeDrug
512,512,infigratinib,NDA,2021,infigratinib,DB11886,approved; investigational,CCN1CCN(CC1)C1=CC=C(NC2=CC(=NC=N2)N(C)C(=O)NC2=C(Cl)C(OC)=CC(OC)=C2Cl)C=C1,Infigratinib,SmallMoleculeDrug
513,513,ibrexafungerp,NDA,2021,ibrexafungerp,DB12471,approved; investigational,[H][C@]12CC[C@@]3([H])[C@@]4(C)COC[C@@]3(C[C@H]([C@@H]4OC[C@](C)(N)C(C)(C)C)N3N=CN=C3C3=CC=NC=C3)C1=CC[C@@]1(C)[C@H](C(O)=O)[C@](C)(CC[C@]21C)[C@H](C)C(C)C,Ibrexafungerp,SmallMoleculeDrug
514,514,finerenone,NDA,2021,finerenone,DB16165,approved; investigational,CCOC1=NC=C(C)C2=C1[C@H](C1=CC=C(C=C1OC)C#N)C(C(N)=O)=C(C)N2,Finerenone,SmallMoleculeDrug
515,515,fexinidazole,NDA,2021,fexinidazole,DB12265,approved; investigational,CSC1=CC=C(OCC2=NC=C(N2C)[N+]([O-])=O)C=C1,Fexinidazole,SmallMoleculeDrug
516,516,belumosudil,NDA,2021,belumosudil,DB16703,approved; investigational,CC(C)NC(=O)COC1=CC=CC(=C1)C1=NC2=C(C=CC=C2)C(NC2=CC=C3NN=CC3=C2)=N1,Belumosudil,SmallMoleculeDrug
517,517,odevixibat,NDA,2021,odevixibat,DB16261,approved; investigational,CCCCC1(CCCC)CN(C2=CC=CC=C2)C2=CC(SC)=C(OCC(=O)N[C@@H](C(=O)N[C@@H](CC)C(O)=O)C3=CC=C(O)C=C3)C=C2S(=O)(=O)N1,Odevixibat,SmallMoleculeDrug
518,518,belzutifan,NDA,2021,belzutifan,DB15463,approved; investigational,CS(=O)(=O)C1=CC=C(OC2=CC(=CC(F)=C2)C#N)C2=C1[C@H](O)[C@H](F)[C@@H]2F,Belzutifan,SmallMoleculeDrug
519,519,difelikefalin,NDA,2021,difelikefalin,DB11938,approved; investigational,CC(C)C[C@@H](NC(=O)[C@@H](CC1=CC=CC=C1)NC(=O)[C@H](N)CC1=CC=CC=C1)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O,Difelikefalin,SmallMoleculeDrug
520,520,mobocertinib,NDA,2021,mobocertinib,DB16390,approved; investigational,COC1=C(NC2=NC=C(C(=O)OC(C)C)C(=N2)C2=CN(C)C3=C2C=CC=C3)C=C(NC(=O)C=C)C(=C1)N(C)CCN(C)C,Mobocertinib,SmallMoleculeDrug
521,521,atogepant,NDA,2021,atogepant,DB16098,approved; investigational,C[C@@H]1[C@@H](C[C@H](NC(=O)C2=CN=C3C[C@]4(CC3=C2)C(=O)NC2=C4C=CC=N2)C(=O)N1CC(F)(F)F)C1=C(F)C(F)=CC=C1F,Atogepant,SmallMoleculeDrug
522,522,maralixibat,NDA,2021,maralixibat,DB16226,approved; investigational,CCCCC1(CCCC)CS(=O)(=O)C2=CC=C(C=C2[C@H]([C@H]1O)C1=CC=C(OCC2=CC=C(C[N+]34CCN(CC3)CC4)C=C2)C=C1)N(C)C,Maralixibat,SmallMoleculeDrug
523,523,avacopan,NDA,2021,avacopan,DB15011,approved; investigational,CC1=CC=C(NC(=O)[C@H]2CCCN([C@H]2C2=CC=C(NC3CCCC3)C=C2)C(=O)C2=C(F)C=CC=C2C)C=C1C(F)(F)F,Avacopan,SmallMoleculeDrug
524,524,asciminib,NDA,2021,asciminib,DB12597,approved; investigational,O[C@@H]1CCN(C1)C1=C(C=C(C=N1)C(=O)NC1=CC=C(OC(F)(F)Cl)C=C1)C1=CC=NN1,Asciminib,SmallMoleculeDrug
525,525,maribavir,NDA,2021,maribavir,DB06234,approved; investigational,CC(C)NC1=NC2=CC(Cl)=C(Cl)C=C2N1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O,Maribavir,SmallMoleculeDrug
526,526,pafolacianine,NDA,2021,pafolacianine,DB15413,approved; investigational,CC1(C)\C(=C/C=C2\CCCC(\C=C\C3=[N+](CCCCS(O)(=O)=O)C4=C(C=C(C=C4)S([O-])(=O)=O)C3(C)C)=C2OC2=CC=C(C[C@H](NC(=O)C3=CC=C(NCC4=CN=C5N=C(N)NC(=O)C5=N4)C=C3)C(O)=O)C=C2)N(CCCCS(O)(=O)=O)C2=C1C=C(C=C2)S(O)(=O)=O,Pafolacianine,SmallMoleculeDrug
527,527,tiludronate disodium,NDA,1997,tiludronate,DB01133,approved; investigational,OP(O)(=O)C(SC1=CC=C(Cl)C=C1)P(O)(O)=O,Tiludronic acid,SmallMoleculeDrug
528,528,ardeparin sodium,NDA,1997,ardeparin,DB00407,approved; investigational; withdrawn,CC(=O)NC1C(O)OC(CO[S](O)(=O)=O)C(OC2OC(C(OC3OC(CO)C(OC4OC(C(O)C(O)C4O[S](O)(=O)=O)C(O)=O)C(O[S](O)(=O)=O)C3N[S](O)(=O)=O)C(O)C2O[S](O)(=O)=O)C(O)=O)C1O,Ardeparin,SmallMoleculeDrug
529,529,risedronate sodium,NDA,1998,risedronate,DB00884,approved; investigational,OC(Cc1cccnc1)([P](O)(O)=O)[P](O)(O)=O,Risedronic acid,SmallMoleculeDrug
530,530,eptifibatide,NDA,1998,eptifibatide,DB00063,approved; investigational,NC(N)=NCCCCC1NC(=O)CCSSCC(NC(=O)C2CCCN2C(=O)C(Cc3c[nH]c4ccccc34)NC(=O)C(CC(O)=O)NC(=O)CNC1=O)C(N)=O,,
531,532,sodium ferric gluconate complex,NDA,1999,ferric gluconate complex,DB09517,approved,C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O[C@]2([C@H]([C@@H]([C@H](O2)CO)O)O)CO)O)O)O)O.C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O[C@]2([C@H]([C@@H]([C@H](O2)CO)O)O)CO)O)O)O)O.C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O[C@]2([C@H]([C@@H]([C@H](O2)CO)O)O)CO)O)O)O)O.C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O[C@]2([C@H]([C@@H]([C@H](O2)CO)O)O)CO)O)O)O)O.C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O[C@]2([C@H]([C@@H]([C@H](O2)CO)O)O)CO)O)O)O)O.C([C@H]([C@H]([C@@H]([C@H](C(=O)[O-])O)O)O)O)O.[O-2].[O-2].[O-2].[Na+].[Fe+3].[Fe+3],Sodium ferric gluconate complex,SmallMoleculeDrug
532,533,pemirolast potassium,NDA,1999,pemirolast potassium,DB00885,approved; investigational,CC1=CC=CN2C(=O)C(=CN=C12)C1=NNN=N1,Pemirolast,SmallMoleculeDrug
533,534,colesevelam hydrochloride,NDA,2000,colesevelam,DB00930,approved,Not found,Colesevelam,SmallMoleculeDrug
534,535,triptorelin pamoate,NDA,2000,triptorelin pamoate,DB06825,approved; vet approved,CC(C)C[C@H](NC(=O)[C@@H](CC1=CNC2=CC=CC=C12)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)NCC(N)=O,Triptorelin,SmallMoleculeDrug
535,536,tinzaparin sodium,NDA,2000,tinzaparin,DB06822,approved,Not found,Tinzaparin,SmallMoleculeDrug
536,537,unoprostone isopropyl,NDA,2000,unoprostone isopropyl,DBSALT001760,approved,CCCCCCCC(=O)CC[C@H]1[C@@H](C[C@@H]([C@@H]1C/C=C\CCCC(=O)OC(C)C)O)O,,
537,538,perflutren lipid microsphere,NDA,2001,perflutren,DB00556,approved,FC(F)(F)C(F)(F)C(F)(F)F,Perflutren,SmallMoleculeDrug
538,539,cefditoren pivoxil,NDA,2001,cefditoren pivoxil,DBSALT001811,approved,[H][C@]12SCC(\C=C/C3=C(C)N=CS3)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CSC(N)=N1)C(=O)OCOC(=O)C(C)(C)C,,
539,540,olmesartan medoxomil,NDA,2002,olmesartan medoxomil,DB00275,approved; investigational,CCCc1nc(c(n1Cc2ccc(cc2)c3ccccc3c4n[nH]nn4)C(=O)OCC5=C(C)OC(=O)O5)C(C)(C)O,Olmesartan,SmallMoleculeDrug
540,541,sodium oxybate,NDA,2002,oxybate,DB09072,approved,C(CC(=O)O)CO,Sodium oxybate,SmallMoleculeDrug
541,542,icodextrin,NDA,2002,icodextrin,DB00702,approved; investigational,OC[C@H]1OC(O[C@H]2[C@H](O)[C@@H](O)C(O[C@@H]2CO)O[C@H]3[C@H](O)[C@@H](O)[C@@H](O)O[C@@H]3CO)[C@H](O)[C@@H](O)[C@@H]1O,Icodextrin,SmallMoleculeDrug
542,544,pentetate calcium trisodium,NDA,2004,pentetate,DB06806,approved,[O-]C(=O)CN(CCN(CC([O-])=O)CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O,,
543,545,pentetate zinc trisodium,NDA,2004,pentetate zinc,DB14007,approved,OC(=O)CN(CCN(CC(O)=O)CC(O)=O)CCN(CC(O)=O)CC(O)=O,Pentetic acid,SmallMoleculeDrug
544,546,lanthanum carbonate hydrate,NDA,2004,lanthanum carbonate hydrate,DB06792,approved,O.[La+3].[La+3].[O-]C([O-])=O.[O-]C([O-])=O.[O-]C([O-])=O,Lanthanum carbonate,SmallMoleculeDrug
545,547,gadobenate dimeglumine,NDA,2004,gadobenate dimeglumine,DB00743,approved; investigational,[Gd+3].OC(=O)CN(CCN(CCN(CC([O-])=O)CC([O-])=O)CC([O-])=O)C(COCC1=CC=CC=C1)C(O)=O,Gadobenic acid,SmallMoleculeDrug
546,548,trypan blue,NDA,2004,trypan blue,DB09158,approved,CC1=CC(=CC=C1\N=N\C1=C(C=C2C=C(C=C(N)C2=C1O)S(O)(=O)=O)S(O)(=O)=O)C1=CC(C)=C(C=C1)\N=N\C1=C(O)C2=C(N)C=C(C=C2C=C1S(O)(=O)=O)S(O)(=O)=O,Trypan blue free acid,SmallMoleculeDrug
547,550,clofarbine,NDA,2004,clofarbine,DB00631,approved,[H][C@]1(F)[C@H](O)[C@@H](CO)O[C@H]1N1C=NC2=C(N)N=C(Cl)N=C12,Clofarabine,SmallMoleculeDrug
548,551,kunecatechins,NDA,2006,kunecatechins,DB01266,nutraceutical,Not found,Sinecatechins,SmallMoleculeDrug
549,552,fosaprepitant dimeglumine,NDA,2008,fosaprepitant dimeglumine,DB06717,approved,C[C@@H](O[C@H]1OCCN(CC2=NC(=O)N(N2)P(O)(O)=O)[C@H]1C1=CC=C(F)C=C1)C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F,Fosaprepitant,SmallMoleculeDrug
550,553,gadoxetate disodium,NDA,2008,gadoxetate,DB08884,approved,[Gd+3].[H][C@@](CN(CCN(CC([O-])=O)CC([O-])=O)CC([O-])=O)(CC1=CC=C(OCC)C=C1)N(CC(O)=O)CC(O)=O,Gadoxetic acid,SmallMoleculeDrug
551,554,gadofosveset trisodium,NDA,2008,gadofosveset,DB06705,contrast,Not found,Gadofosveset trisodium,SmallMoleculeDrug
552,555,omacetaxine mepesuccinate,NDA,2012,omacetaxine,DB04865,approved,[H][C@@]1(OC(=O)[C@@](O)(CCCC(C)(C)O)CC(=O)OC)C(OC)=C[C@]23CCCN2CCC2=CC4=C(OCO4)C=C2[C@]13[H],Omacetaxine mepesuccinate,SmallMoleculeDrug
553,556,gadoterate meglumine,NDA,2013,gadoterate meglumine,DB09132,approved,[Gd+3].CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC(=O)CN1CCN(CCN(CCN(CC1)CC([O-])=O)CC([O-])=O)CC([O-])=O,Gadoteric acid,SmallMoleculeDrug
554,557,dimethyl fumarate,NDA,2013,dimethyl fumarate,DB08908,approved; investigational,[H]\C(=C(\[H])C(=O)OC)C(=O)OC,Dimethyl fumarate,SmallMoleculeDrug
555,558,dalbavancin,NDA,2014,dalbavancin,DB06219,approved; investigational,CN[C@H]1C(=O)N[C@@H]2Cc3ccc(Oc4cc5cc(Oc6ccc(cc6Cl)[C@@H](O)[C@@H]7NC(=O)[C@H](NC(=O)[C@@H]5NC(=O)[C@@H](NC2=O)c8cc(Oc9cc1ccc9O)cc(O)c8Cl)c%10ccc(O)c(c%10)c%11c(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]%12O)cc(O)cc%11[C@@H](NC7=O)C(=O)NCCCN(C)C)c4O[C@@H]%13O[C@@H]([C@@H](O)[C@H](O)[C@H]%13NC(=O)CCCCCCCCC(C)C)C(O)=O)cc3,Dalbavancin,SmallMoleculeDrug
556,559,sulfur hexafluoride lipid-type A microspheres,NDA,2014,sulfur hexafluoride lipid-type A microspheres,DB11104,approved,Not found,Sulfur hexafluoride,SmallMoleculeDrug
557,560,sodium zirconium cyclosilicate,NDA,2018,zirconium cyclosilicate,DB14048,approved,Not found,Sodium zirconium cyclosilicate,SmallMoleculeDrug
558,561,tafamidis meglumine,NDA,2019,tafamidis meglumine,DB11644,approved; investigational,OC(=O)C1=CC=C2N=C(OC2=C1)C1=CC(Cl)=CC(Cl)=C1,Tafamidis,SmallMoleculeDrug
559,562,Brilliant Blue G Ophthalmic Solution,NDA,2019,Brilliant Blue G Ophthalmic Solution,DB15594,approved,CCN(CC1=CC(=CC=C1)S(=O)(=O)(=O))C2=CC(=C(C=C2)/C(=C/3\C=CC(=[N+](CC)CC4=CC(=CC=C4)S(=O)(=O)(=O))C=C3C)/C5=CC=C(C=C5)NC6=CC=C(C=C6)OCC)C,Brilliant blue G,SmallMoleculeDrug
